Neural correlates of cognitive impairment in patients with multiple sclerosis by Geisseler, Olivia
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2016
Neural correlates of cognitive impairment in patients with multiple sclerosis
Geisseler, Olivia
Abstract: Unspecified
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: http://doi.org/10.5167/uzh-124505
Published Version
Originally published at:
Geisseler, Olivia. Neural correlates of cognitive impairment in patients with multiple sclerosis. 2016,
University of Zurich, Faculty of Arts.
Neural correlates of cognitive
impairment in patients with multiple
sclerosis
Cumulative thesis
presented to the Faculty of Arts and Social Sciences
of the University of Zurich
for the degree of Doctor of Philosophy
by
Olivia Allegra Geisseler
of Lucerne, Switzerland
Accepted in the fall semester 2015
on recommendation of the doctoral committee:
Prof. Dr. rer. nat. Lutz Ja¨ncke
Prof. Dr. med. Michael Linnebank
Prof. Dr. rer. nat. Peter Brugger
Zurich 2016

Acknowledgments
First of all, I would like to express my very special thanks to Prof. Peter Brugger
for his competent advisory, professional support, for sharing his rich experience and
immense knowledge in all research and clinical related questions. Furthermore, I
am very grateful that I was given the opportunity to learn - beside the research
work - the clinical skills of neuropsychology. Thank you! Further, I would also like
to thank Prof. Michael Linnebank for his support and mentoring and for giving
me the possibility to do a PhD at the Clinic of Neurology at the University Hos-
pital of Zurich in the research field of multiple sclerosis. I would also like to thank
Prof. Lutz Ja¨ncke for being part of my PhD steering committee. He attracted my
attention for neuroscience with his entertaining and fascinating lectures and thus,
lay the basis of this thesis.
I am particularly indebted Dr. Tobias Pflugshaupt for his enormous support
and motivation throughout the past three years. I am tremendously grateful for
the countless hours he has invested in discussing ideas and findings, revising my
manuscripts as well as his permanent enthusiasm for our research. I am also very
grateful to Dr. Ladina Bezzola, who offered invaluable assistance and support
with the MRI data analysis and shared her immense imaging knowledge with me.
Particularly, I appreciated the motivation she gave me in the hard times of the
PhD.
I would also like to thank Adi, Manuela, Regula and Ladina for proofreading this
thesis.
A very special thanks goes to all colleagues of the division of Neuropsychology of
the Clinic of Neurology at the University Hospital of Zurich. I have truly enjoyed
the friendly working environment and I am very grateful for sharing many nice
lunches at the rooftop, a lot of happy Aperos and inspiring discussions.
However, my deepest thanks go to my family for their love and emotional support
throughout my study. Without them, I would not be where I am now. I am eter-
nally grateful to all of them. Thank you!!! Finally, I would like to thank Christoph
for his endless support and the beautiful time we spent together.
This work was supported by a research grant from the Swiss Multiple Sclerosis
Society and Bayer Switzerland.

Summary
The estimated prevalence of cognitive impairment in multiple sclerosis (MS) ranges
from 40 to 70%, affecting all disease stages and subtypes and having devastating
effects on patients’ everyday life. However, the pathological neuronal correlates
are not clarified yet. Thus, this thesis addresses several open questions in the field
of neural correlates of cognitive impairment in MS - with a core focus on cortical
pathology - using structural magnetic resonance imaging (MRI) and an extensive,
carefully selected set of neuropsychological tests. Three studies were conducted as
part of the present thesis, based on a large cohort of 48 relapsing-remitting MS
patients and 48 healthy controls.
Recent studies suggest that cortical lesions in MS are important contributors to
clinical disease severity. Thus, study 1 was set out to compare MS patients with
and without cortical lesions regarding cognitive functioning, but also regarding
demographic and basic disease characteristics. The result showed that mnestic
impairment is a typical feature of cortical affection in MS and propose a so-called
‘cortically dominant’ MS subtype.
Despite the increasing amount of correlational studies between neuroanatomical
alterations and cognitive dysfunction in MS, topological studies on specific cogni-
tive functions are very rare. Study 2 was set out to fill this gap by investigating
neurostructural correlates of executive dysfunction in MS patients and healthy
controls, both on a global and a regional level. The results reveal two important
findings: First, on a behavioral level, we find that executive dysfunction in MS
patients appears to specifically affect fluency. Second, we show a lateralized clinico-
anatomical correlation pattern between fluency performance and cortical thickness
in the anterior cingulate cortex, a finding previously described in brain-damaged
patients with large lesions only, for example after stroke. The lateralized pattern
described here appears novel and quite unique in the literature on MS, a disease
affecting the two hemispheres in a comparable way and usually characterized by
its widespread pathology.
Human subjects typically deviate systematically from randomness when attempt-
ing to produce a sequence of random numbers. Study 3 investigated, for the first
time, the impact of MS on random number generation (RNG) and its neurostrucu-
tral correlates. The behavioral results illustrate a loss of behavioral complexity in
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the course of MS while imaging results argue for an association between cortical
pathology - in terms of cortical lesions and atrophy - and RNG performance.
With these studies, we contribute to a better understanding of cognitive impair-
ment in patients suffering from MS, highlighting the relevance of cortical pathology
for cognitive functioning in MS and, thus, adding a small puzzle piece to this vast
field of MS cognition research.
Zusammenfassung
Bei 40-70% der Patienten mit Multipler Sklerose (MS) treten im Verlauf der
Erkrankung kognitive Defizite auf, unabha¨ngig von Erkrankungsdauer oder -form.
Diese Dysfunktionen ko¨nnen den Alltag und damit die Lebensqualita¨t der Be-
troffenen erheblich beeinflussen. Dennoch sind die pathologisch-neuronalen Ko-
rrelate bis heute nicht ga¨nzlich bekannt. Die vorliegende Doktorarbeit hat zum
Ziel, mittels struktureller Magnet Resonanz Tomographie (MRT) und einer um-
fassenden Anzahl sorgfa¨ltig ausgewa¨hlter neuropsychologischer Tests offenen Fra-
gen bezu¨glich neuronaler Korrelate kognitiver Beeintra¨chtigungen bei MS-Patienten
nachzugehen. Der Schwerpunkt liegt dabei in der kortikalen Pathologie. Drei Stu-
dien wurden im Rahmen dieser Arbeit durchgefu¨hrt. All diese basieren auf einer
grossen Stichprobe von 48 MS-Patienten und 48 gesunden Kontrollen.
Ju¨ngste Studien haben gezeigt, dass kortikale La¨sionen zur Schwere der Erkrankung
beitragen. Daher wurden in der Studie 1 MS-Patienten mit kortikalen La¨sionen
und solche ohne miteinander verglichen; dies einerseits bezu¨glich kognitiver Funk-
tionen, anderseits bezu¨glich demographischer Unterschiede oder anderer krankheits-
bezogener Charakteristika. Es zeigte sich, dass mnestische Defizite kennzeich-
nend sind fu¨r eine kortikale Beteiligung der Krankheit. Daher schlagen wir einen
”kortikal-dominanten” Subtyp der MS vor.
Trotz einer zunehmenden Anzahl Korrelationsstudien, die den Zusammenhang
zwischen strukturellen Vera¨nderungen und kognitiven Defiziten untersucht haben,
fehlt es an topologischen Studien, die sich auf spezifische kognitive Defizite beziehen.
Mit Studie 2 wurde versucht diese Lu¨cke zu schliessen. Es wurden neurostruk-
turelle Korrelate der Exekutivfunktionen bei MS-Patienten und gesunden Kon-
trollpersonen untersucht, und zwar sowohl auf globaler als auch auf fokaler Ebene.
Zwei wichtige Befunde ergaben sich: Erstens zeigte sich auf der Verhaltensebene,
dass exekutive Dysfunktionen bei MS-Patienten ausschliesslich die Ideenproduk-
tion betreffen. Zweitens, fanden wir ein lateralisiertes klinisch-anatomisches Kor-
relationsmuster zwischen Leistung in der Ideenproduktion und kortikaler Dicke im
anterioren cingula¨ren Kortex. A¨hnliche Ergebnisse wurden bereits bei hirngescha¨-
digten Patienten mit grossen fokalen La¨sionen gezeigt (z.B. Schlaganfallpatienten).
Das beschriebene lateralisierte Muster ist hingegen neu und einzigartig in der Lit-
eratur betreffend MS, eine Krankheit, die beide Hirnhemispha¨ren in vergleichbarer
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Weise scha¨digt und charakterisiert wird durch ihre ausgedehnte Pathologie.
Beim Versuch zufa¨llige Zahlensequenzen zu produzieren weichen Menschen typis-
cherweise systematisch von der theoretischen Zufa¨lligkeit ab. Studie 3 untersuchte,
zum ersten Mal, den Einfluss von MS auf die Zufallsgenerierung von Zahlen und
deren neurostrukturelle Korrelate. Die Resultate ergaben einen Verlust an Ver-
haltenskomplexita¨t bei MS Patienten. Die bildgegebenden Analysen zeigten einen
Zusammenhang zwischen kortikaler Pathologie (im Sinne von kortikalen La¨sionen
und Atrophie) und der Leistung in der Zufallsgenerierung von Zahlen.
Mit diesen drei Studien verbessern wir das Versta¨ndnis kognitiver Beeintra¨chtigun-
gen bei MS-Patienten, indem die Bedeutung kortikaler Pathologie fu¨r die geistige
Leistungsfa¨higkeit herausgestrichen wird. Hiermit leisten wir einen kleinen Beitrag
im umfassenden Gebiet der MS Kognitionsforschung.
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1 Introduction
”A cette expression dominante de la physionomie correspond presque
toujours un e´tat mental qui me´rite d’eˆtre signale´. Il y a un affaiblisse-
ment marque´ de la me´moire; les conceptions son lentes; les faculte´s
intellectuelles et affectives e´mousse´es dans leur ensemble.”
Jean Martin Charcot, 1877
Since this first description of cognitive impairment in patients suffering from mul-
tiple sclerosis (MS) by Jean-Martin Charcot - the founder of modern neurology -
a lot of work has been done. In the second half of the 20th century, it became
more and more evident that cognitive impairment is a frequent feature of MS and
clinicians have become increasingly aware of the profound functional impact of
cognitive impairment in MS. During the past three decades, much effort has been
put into the characterization of the extent, type and reasons of cognitive disability
in patients with MS. The main driving forces of research in this area is the need to
better explain the heterogeneous and complex manifestation of cognitive impair-
ment in MS patients in order to develop potential prevention and novel therapeutic
interventions. Through these studies, many advances have been made concerning
our understanding of cognitive impairment in MS. However, many aspects still
need to be considered.
This doctoral thesis tries to extend our knowledge about cognition and the neural
underpinnings in patients suffering from MS. The focus will be on several aspects
of structural magnetic resonance imaging to investigate neuroanatomical correlates
of cognitive impairment in MS patients, with a core focus on cortical pathology.
The following section (Chapter 2) addresses the question what MS is and outlines
the theoretical background and previous research, which was derived in the field
of cognition and structural imaging in MS. Chapter 3 outlines the aims of the
empirical work and emphasizes the relevance of this thesis. Chapter 4 describes
the study sample and gives a short introduction into the methods used in the three
studies conducted as part of the present doctoral thesis. Chapter 5 includes the
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the three empirical studies comprising their results and discussion. To conclude,
Chapter 6 gives a summary of the results and a general discussion.
2 Theoretical background
2.1 Epidemiology, etiology and subtypes of MS
Multiple sclerosis means ’multiple scarring’ or ’hardening’ (Wiendl & Kieseier,
2010) and is also know as ’disseminated sclerosis’ or ’encephalomyelitis dissemi-
nata’ (Netter, 2007). It is one of the most common disabling neurologic disease in
young adults, affecting more than 10’000 people in Switzerland (Multiple Sclerosis
Society of Switzerland, 2015). Generally, MS has a prevalence ranging from 2 to
150 in 100’000 people (Rosati, 2001), depending on the country or specific popula-
tion (Koutsouraki, Costa, & Baloyannis, 2010). In contrast to other neurological
conditions, MS has an early onset in young adult life, with symptoms typically
beginning in the third or fourth decade of life. The disease shows a female pre-
dominance of 2:1 to 3:1 (Chiaravalloti & DeLuca, 2008).
The etiology of MS is thought to be multifactorial. Epidemiological data in-
dicate that both environmental (e.g. latitude, vitamin D, smoking, Epstein-
Barr virus) and genetic factors are important contributors to disease development
(Ramagopalan, Dobson, Meier, & Giovannoni, 2010), however, the specific ele-
ments remain unclear. Genetic susceptibility explains the clustering of MS cases
within families, whereas the changes in MS risk that occur with migration can be
explained only by changes in the environment (Ascherio, 2013). A recent metaanal-
ysis about the environmental risk factors identified a biomarker of Epstein-Barr
virus (anti-EBNA IgG seropositivity), infectious mononucleosis, and smoking to
show the strongest consistent evidence of an association with disease development
(Belbasis, Bellou, Evangelou, Ioannidis, & Tzoulaki, 2015). In contrast, a protec-
tive effect on the risk of MS has been proposed for vitamin D (Munger et al., 2004;
Salzer et al., 2012).
Three main clinical subtypes of MS have been identified (Figure 2.1). Relapsing-
remitting MS (RRMS), affecting about 85% of the newly diagnosed patients, is
characterized by clearly defined attacks - often called relapses - of worsening of
symptoms. Between the relapses, substantial or complete recovery are noted.
Over time, the majority of RRMS patients (80%) enter a phase in which there
is continuous deterioration, known as secondary-progressive MS (SPMS), i.e. a
gradual decline with or without occasional relapses or remissions. Approximately
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Figure 2.1: Graphs of the three main MS subtypes.
10 to 15% of patients experience a primary progressive (PPMS), relatively non-
inflammatory disease course from the onset with a characteristic steady worsening
of neurologic functioning, without any distinct relapses or periods of remission.
Furthermore, clinically isolated syndrome (CIS) is a term describing a first clinical
episode in which patients have symptoms and signs suggestive of an inflamma-
tory demyelinating disorder of the central nervous system (CNS) (Miller, Chard,
& Ciccarelli, 2012). Often, but not always, it progresses to MS.
2.2 Pathophysiology
After more than a century, of research the precise pathogenesis of MS still remains
unclear. The full complexity of the ongoing debate of the pathophysiology of MS
is beyond the scope of this thesis, but the most important findings are shortly
introduced in order to provide a background for the subsequent sections.
Traditionally, MS is considered to be an autoimmune inflammatory disorder (E. Fox,
2004), in which dysregulated auto-reactive T cells in the periphery cross into the
CNS through a pathological disruption of the blood-brain barrier and, together
with macrophages and B cells, proceed to destroy CNS elements, particularly
myelin (Stys, Zamponi, van Minnen, & Geurts, 2012). In areas of demyelination,
sclerotic plaques are formed and the normal transmission of the action potential
might be disrupted. This disseminated focal demyelinating lesions in the white
matter (WM) are the pathological hallmark of MS. However, by now it is known,
that MS have effects beyond the loss of the myelin sheath (Purves et al., 2008).
Inflammatory demyelination can lead to irreversible axonal and dendritic damage,
transection and loss, defined as secondary degeneration. Beyond that, it has been
proposed lately that MS might be even a degenerative disorder such as Alzheimer’s
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and Parkinson’s disease (Hauser & Oksenberg, 2006; Trapp & Nave, 2008), where
primarily the axon selectively degenerate, followed by demyelination in the sec-
ondary phase. Evidence for this primary degenerative process comes from careful
pathological examinations showing that outer myelin wraps are often still intact,
whereas myelin abnormalities are observed at the inner myelin sheath. Similar to
the indisputable inflammatory character of the disease which has been challenged,
the traditionally view of MS as a WM disease has been faced. Thus, in the re-
cent years, it became clear that the grey matter (GM) is not spared. However,
the underlying mechanisms inducing GM pathology remains unclear. Since the
first evidence of cortical involvement in MS, there is an ongoing debate about the
extent to which GM pathophysiology is similar to that in WM. Recently, several
mechanisms including either primary (arising within GM regions) or secondary
(as a result of ongoing damage in the WM) pathogenic processes have been pro-
posed. One of the main theories about the pathogenesis of GM lesions suggests
that meningeal inflammation and associated myelinotoxic agents that might be
produced in the meninges and then diffuse into the cortex could be causally re-
lated to cortical demyelination (Geurts, Calabrese, Fisher, & Rudick, 2012). Other
alternative theories proposed several secondary disease mechanisms, where GM
damage results from ongoing damage in the WM. Calabrese and colleagues (2015)
conclude in their very recent review about the origins of GM damage in multiple
sclerosis, that GM damage proceeds in a manner that is partly independent of
WM damage, although they assume clearly some degree of relationship between
the two types of damage. Support for an independent mechanisms is coming from
MS cases exhibiting predominantly GM pathology with little WM involvement,
and vice versa. Thus, it seems that the inflammatory processes affecting the GM
occurs, at least partly, independent of WM inflammation. Furthermore, they re-
port inflammatory and neurodegenerative mechanisms involved in GM pathology.
However, the relationship between the two remains unclear. It can be concluded
that the pathophysiology of MS seems to be a complicated picture that remains
to be elucidated.
2.3 Structural imaging and neuroanatomical
changes in MS
Although computed tomography (CT) can in some cases depict hypodensitiy
within particularly severe MS lesions, magnetic resonance imaging (MRI) is con-
sidered the most sensitive imaging modality for MS (R. Fox, 2008). Different
tissue types (e.g. GM, WM, cerebrospinal fluid (CSF)) and tissue alterations ex-
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Figure 2.2: Different MRI scans from MS patients showing characteristic lesions. A) T1-weighted
image showing a black hole (red arrow) and hyperintense gadolinium-enhanced lesion (blue ar-
row) B) Another T1-weighted image from a MPRAGE (Magnetization prepared rapid gradient
echo) scan with black holes (red arrows). C) T2-weighted image from a MS patient, showing
characteristic lesions, so called T2-lesions or plaques (yellow arrow) D) DIR sequence showing
cortical lesions (green arrow). Source: Geisseler (2012)
hibit differential magnetic properties resulting in this high sensitivity for structural
changes in MS. Its ability to depict the pathological features in exquisite detail,
conventional MRI is widely applied to ascertain the diagnosis in patients suspected
of MS and plays an important role in monitoring the evolving disease in vivo. Fur-
thermore, it has become a major outcome measure in clinical trials and other
scientific investigations (Barkhof, 2002). In fact, it is incorporated into the formal
diagnostic algorithm for MS since 2001 (McDonald et al., 2001) - with new lesions
fulfilling either dissemination in space or dissemination in time criteria (Bakshi
et al., 2008) - and has an established role in the exclusion of clinically similar
conditions (Charil et al., 2006). In the following two sections, the most important
neuroanatomical changes in MS patients assessed with MRI will be introduced.
2.3.1 Focal lesions
Conventional MRI in the clinical routine includes T1- and T2-weighted sequences,
the lalter with and without gadolinium-based contrast agent (Figure 2.2). In-
flammation and demyelination within the CNS causes a prolongation in the T2-
relaxation time, resulting in focal areas of hyperintensity on T2-weighted images
(Figure 2.2 C) (Barkhof & van Walderveen, 1999). These signal changes are so
called T2-lesions or plaques - the hallmark of MS. When the tissue injury is severe,
MS lesions can cause T1-prolongation, which appears dark on T1-weighted images
(R. Fox, 2008). These ’black holes’ represent irreversible tissue destruction and
axon loss (Bermel & Bakshi, 2006) (Figure 2.2 A and B). Gadolinium-enhanced
T1-weighted MR images allow to distinguish active inflammatory lesions - indica-
tive for a relapse - from inactive lesions, since enhancement occurs as a result of
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Figure 2.3: Spatial distribution of T2-hyperintense lesions in 48 MS patients based on normalized
lesion. Lesion frequency across the sample is displayed for every depicted voxel. Color bar
indicates the number of patients showing damage to a particular voxel. Source: Unpublished
data from University Hospital Zurich
increased blood-brain barrier permeability (Filippi & Rocca, 2011) (Figure 2.2 A,
blue arrow). Although lesions can occur anywhere in the CNS, there are certain
sites of predilection (McDonald & Ron, 1999). WM lesions have been predom-
inantly found in near the borders of the lateral ventricles (periventricular), as
illustrated in Figure 2.3. The classical view of MS as a pure WM pathology has
not been overcome until the beginning of the 21st century, even though first histo-
logical reports of demyelinated foci in the cortex of patients with MS date back to
the beginning of the 20th century (Dawson, 1916). By now, grey matter involve-
ment in the pathology of MS is well established (for reviews see Geurts & Barkhof,
2008; M. Calabrese, Magliozzi, et al., 2015) and is recognized as s feature in most
MS patients. The traditional view of MS as a WM disease was driven by the
higher sensitivity of the conventional MRI techniques to WM changes (Horakova,
Kalincik, Blahova Dusankova, & Dolezal, 2012). Cortical lesions are typically rel-
atively small, have longer relaxation times than those of WM (Kidd et al., 1999)
and have poor contrast against the surrounding normal GM (Bagnato et al., 2006).
A significant improvement in the in vivo detection of GM lesion was obtained by
a novel MRI technique, called double inversion recovery (DIR) sequences (Figure
2.2). It shows an improved sensitivity to GM changes by suppressing the signal
from the CSF and the WM (Filippi & Rocca, 2011). Even though, a recent study
has shown that DIR sequences detect only a minority of cortical lesions in MS
(Seewann et al., 2012), it is currently considered to be the best pulse sequence for
cortical lesion detection and still has an excellent pathologic sensitivity.
In recent years, much effort has been put into describing and classifying pathology
within GM areas, resulting in a currently widely used scoring system that dis-
tinguishes between four major cortical lesion types. Type I lesions are combined
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WM/GM lesions. Type II lesions are entirely located within the cerebral cortex
and are not in direct contact with subcortical WM. Type III are subpial cortical
demyelination, reaching from the pia downwards into the cortex. Lesions com-
prising the entire width of the cortex, without spreading in the subcortical WM
are categorized as type IV lesions (Bø, Vedeler, Nyland, Trapp, & Mørk, 2003a,
2003b). Cortical lesions have been reported to vary significantly among the differ-
ent cortical areas, being the cingulate gyrus, the temporal and frontal cortices the
mostly affected (Bø et al., 2003b, e.g). Although cortical lesions can be seen at all
stages of the disease their incidence and size increases with disease duration and
accumulate over time (M. Calabrese, Rocca, et al., 2010).
2.3.2 Atrophy
In addition to focal lesions, another well-known feature of MS is brain atrophy
(Barkhof, 2002), affecting not only the WM, but also the GM. Until the beginning
of the 21th century, it was difficult to quantify changes in brain volume with any
precision. Improvements in methods to assess brain volumes from conventional
MRI scans have allowed to sensitively and reproducibly quantify the extent of tis-
sue loss in GM and WM separately and to study the distribution of atrophy at a
regional level.
Most easily noticeable is the presence of diffuse global atrophy as reflected by en-
largement of the ventricular system and sulcal widening (Sicotte, 2011) (Figure
2.4 B). However, a reduction of global white and grey matter volume has been
observed, too. Furthermore, it has been established that corpus callosum atro-
phy occurs in MS and that it can be reliably measured (Figure 2.4 A). Whereas
the detection of focal GM lesions was, and still is, challenging using conventional
MRI sequences, GM atrophy can be robustly and reliably measured form stan-
dard MRI (Fisher, Lee, Nakamura, & Rudick, 2008) using various methods. The
involvement of both, cortical and several subcortical GM structures, such as the
thalamus (Houtchens et al., 2007) or hippocampus (Sicotte et al., 2008), has been
demonstrated. For the first time, Sailer and colleagues (2003) described changes
in absolute thickness of the cortical ribbon of MS patients. On the one hand,
they showed a significant overall thinning of the cerebral cortex in MS patients
compared to controls, on the other hand, they described a distinct distribution of
focal atrophy. Supporting these early findings, several more recent studies showed
a in-homogeneously distribution of cortical atrophy (Benedict et al., 2005; M. Cal-
abrese, Rinaldi, et al., 2010; Riccitelli et al., 2011; Tekok-Kilic et al., 2007) with a
predominant involvement of temporal and frontal regions.
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Figure 2.4: MRI markers of MS-related brain atrophy. Based on two RRMS patients, one with
considerable atrophy (upper row), the other with no atrophy (lower row). A) Mid-sagittal T2-
weighted images depicting prominent thinning of the corpus callosum (white arrows) in the
upper patient. B) Axial T2-weighted images illustrating ventricular widening including the third
ventricle (white arrows) in the upper patient. Moreover, sulcal widening is visible in the region
of the left Sylvian fissure. Horizontal image orientation follows the radiological convention (right
on left side). Source: Pflugshaupt et al. (2015)
2.4 Clinical presentation of MS
One of the characteristics of MS is the variability of its symptoms, as it affects
all parts of the CNS. No two patients have exactly the same symptoms, and each
person’s symptoms can change or fluctuate over time, indicating also a high intra-
individual variability. However, despite the broad range of symptoms, some of
them are more prevalent than others. Common MS symptoms are walking (gait)
disorders, weakness, vision disturbance, numbness or tingling, dizziness, vertigo,
bladder or bowel dysfunction (Kesselring & Beer, 2005). In addition to the neu-
rological symptoms that characterize MS, the disease is associated with a range
of behavioral disorders. These include depression, fatigue, cognitive impairment,
bipolar affective disorder, anxiety disorders, euphoria, pathological laughing and
crying as well as psychosis (Feinstein, DeLuca, Baune, Filippi, & Lassman, 2013).
The most common behavioral disorder is major depression, which is three times
more prevalent in MS patients relative to the general population (Siegert & Aber-
nethy, 2005). However, fatigue is the most common complaint of MS generally,
independent of the clinical subtype and the stage of the disease (MacAllister &
Krupp, 2005). According to different studies, 53 to 90% of patients with MS ex-
perience cognitive and/or physical fatigue (Krupp, LaRocca, Muir-Nash, & Stein-
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berg, 1989; Krupp, Alvarez, LaRocca, & Scheinberg, 1988; Penner et al., 2007).
Cognitive fatigue is defined as a decline in cognitive performance over a brief pe-
riod of time, such as a neuropsychological testing session lasting approximately 2
hours or part of a workday (Julian, 2011), whereas physical fatigue is defined as a
sense of exhaustion, lack of physical energy, or tiredness (Krupp, 2006). Fatigue is
frequently reported by patients to be the most disabling symptom of the disease
(Giovannoni, 2006), probably as it interferes with work, family and social activities
(Rocca et al., 2014). In addition to the symptom variability, also the course of MS
is highly variable and unpredictable. On the one hand, rare cases are fatal in less
than a year, on the other hand, occasional patients have little disability even after
50 years of disease (McDonald & Ron, 1999). However, often there is a substantial
correlation between physical disability and disease duration.
All these functional deficits, including the physical disability and neuropsychiatric
symptoms, are determinants of quality of life (DeLuca & Nocentini, 2011; Mitchell,
Benito-Leon, Gonzalez, & Rivera-Navarro, 2005; Penner, Kappos, Rausch, Opwis,
& Radu, 2006) and lead to a loss of independence and restriction in social activi-
ties. Furthermore, they are strongly associated with work disability (Bøe Lunde et
al., 2014; Strober et al., 2012) and cause in up to 80% of the cases unemployment
within a ten-year disease course (Rao, Leo, Ellington, et al., 1991).
Krutzke (1983) developed the Expended Disability Status Scale (EDSS) for quan-
tifying and evaluating disability resulting from MS. It is the most widely accepted
and applied neurological rating scale for MS. The EDSS provides a score on a scale
ranging from 0 (normal neurologic examination) to 10 (death due to MS) incre-
menting in 0.5 units. The scale measures impairment or activity limitation based
on the examination of seven functioanl systems: Pyramidal, cerebellar, brainstem,
sensory, bowel and bladder function, visual function, cerebral (or mental) func-
tions. Between 0 and 4.5 people are able to walk without assistance, EDSS steps
5.0 to 9.5 are defined by the impairment to walk.
2.5 Cognition in MS
Already Jean-Martin Charcot described in his pioneer work cognitive impairment
in patients with MS (Charcot, 1877). However, the topic generated little inter-
est, and cognitive deficits have largely been neglected for many decades. This
may be due to the observation that MS patients rarely show classical neuropsy-
chological syndromes such as agnosia, aphasia, apraxia, or acalculia (Rao, 1986).
Only lately, awareness of cognitive dysfunction in MS patients has increased and
clinicians have become increasingly aware of the profound functional impact of
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cognitive impairment in MS. During the last three decades, essential contributions
to the understanding of cognitive deficits were made. By now, it is known that
45-70% of the MS patients are cognitively impaired (Amato, Zipoli, & Portac-
cio, 2006; Benedict, Cookfair, et al., 2006a; Rao, Leo, Bernardin, & Unverzagt,
1991). Cognitive deficits can appear in all disease stages and subtypes (Langdon,
2011). Beside RRMS, SPMS and PPMS, even in the earliest manifestations of the
disease (CIS), cognitive deficits can be observed (Potagas et al., 2008). However,
cognitive impairment is more prevalent and severe in progressive forms of MS com-
pared to RRMS (DeLuca & Nocentini, 2011) and generally tend to increase over
time (Amato et al., 2006), but more slowly and less consistently than in neurode-
generative disorders such as Alzheimer. Amato and colleagues (2001) showed in
a longitudinal study that the prevalence of cognitive dysfunction increased from
26% to 56% in sample of MS patients over a period of 10 years. Remission of
cognitive symptoms is uncommon.
Cognitive dysfunctions often result in significant functional impairment at work
and at home, sometimes despite minimal physical disability (Elsass & Zeeberg,
1983). There are studies showing cognitive impairment in patients with little or
no physical disability, usually assessed by the EDSS (Beatty, Goodkin, Hertsgaard,
& Monson, 1990; Franklin, Nelson, Filley, & Heaton, 1989; Marsh, 1980). More-
over, there are observations that cognitive problems are frequently present even
when other signs and symptoms of MS are absent in the neurologic examination.
However, no clear associations have been found between cognitive dysfunction and
measures of physical disability (Elsass & Zeeberg, 1983).
The extend of cognitive decline is wide. The question why some MS patients
develop severe impairment in cognitive abilities, while cognitive functions remain
intact in others is still unanswered (Benedict & Zivadinov, 2011). Factors such as
age, gender, age at disease onset, level of education and cognitive reserve may have
an influence on cognitive abilities and cause the extreme variability of cognitive
impairment (Horakova et al., 2012). Advanced age and depression are discussed
as potential risk factors for cognitive decline in MS patients, while consistent with
the cognitive reserve hypothesis a high premorbid intellectual level of MS patients
can protect from cognitive decline (Sumowski, Wylie, Gonnella, Chiaravalloti, &
Deluca, 2010). The cognitive reserve hypothesis states that intellectual enrich-
ment lessens the negative impact of neurological disease on cognitive status (Stern,
2009). Rare cases, in which cognitive impairment resembles dementia, are known
(Julian, 2011), yet severe dementia in accordance with the criteria of the ICD-10
is relatively uncommon.
Another controversy concerns the relation of cognitive impairment to other fre-
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quent MS symptoms, such as fatigue or depression. There are studies showing
depression, anxiety and fatigue aggravate symptoms. Early studies have generally
not found an association between depression and cognitive impairments in MS.
Whereas a very recent study has found significant positive correlations between
self-reported fatigue and cognitive test performance (Neumann et al., 2014), oth-
ers failed to show such association (Morrow, Weinstock-Guttman, Munschauer,
Hojnacki, & Benedict, 2009).
2.5.1 Impaired cognitive domains
The heterogeneity of the cerebral pathology of MS understandably results in great
variety of cognitive problems (Benedict & Zivadinov, 2011; Huijbregts, Kalkers,
de Sonneville, de Groot, & Polman, 2006). MS-related cognitive function affect
various aspects of cognition. Probably the most consistently reported and pri-
mary cognitive deficit in MS is slowed information processing speed, which is well
documented in many studies (e.g., Chiaravalloti & DeLuca, 2008; Roth, Denney,
& Lynch, 2015; DeLuca, Chelune, Tulsky, Lengenfelder, & Chiaravalloti, 2004;
Denney, Gallagher, & Lynch, 2011) and was already described by Charcot (1877).
Patients have difficulty to think quickly or to keep up with conversation, and in
neuropsychological assessments, they complete substantially fewer items on tests
such as the Paced Auditory Serial Addition Test (PASAT; Kujala, Portin, Revon-
suo, and Ruutiainen (1995)) or Symbol Digit Modalities Test (Parmenter, Shucard,
& Shucard, 2007). Simplified, they feel ”slowed down” mentally (Fischer, 2001,
p. 236). Decrements in information processing speed are associated with other
cognitive deficits common in MS, such as working memory and long-term memory
(Chiaravalloti & DeLuca, 2008).
The other cognitive domain most commonly affected in patients with MS is an-
terograde episodic memory. Moreover, impaired memory is the most investigated
cognitive deficit in MS and is regularly observed in MS patients - sometimes even
reported as the most frequently disrupted cognitive domain (Rogers & Panegyres,
2007). There has been disagreement on the nature of MS-related memory impair-
ment. In the 1980s, it has been suggested that cognitive impairment in MS becomes
manifest as subcortical dementia (Beatty, Goodkin, Monson, & Beatty, 1989; Rao,
1986), which is characterized by slowness of mental processing, forgetfulness, im-
paired conceptual reasoning and planning, apathy, and depression, in the absence
of agnosia, aphasia, dense amnesia, which are typical signs for cortical dementias
such as Alzheimer’s disease (Cummings & Benson, 1984). Thus, early work has
suggested difficulty in retrieval as the core deficit in memory. However, the view of
MS-related cognitive impairment as a variant of subcortical dementia was disputed
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(P. Calabrese & Penner, 2007) by studies showing that memory problems are not
restricted to difficulties in retrieving information (e.g. forgetfulness) but can also
affect initial learning of information (DeLuca, Barbieri-Berger, & Johnson, 1994;
Deluca, Leavitt, Chiaravalloti, & Wylie, 2013). Furthermore, problems in mem-
ory span (Thornton & Raz, 1997) or recognition (DeLuca, Gaudino, Diamond,
Christodoulou, & Engel, 1998) have been observed. Memory impairment seems
much more global than implied by the concept of subcortical dementia (Thornton
& Raz, 1997). Moreover, and as elucidated above, neuroimaging studies high-
lighted cortical affection of the MS pathology, putting the usefulness of the term
’subcortical dementia’ into question, when describing cognitive impairment in MS.
Studies on executive functions - the cognitive abilities needed for complex goal-
directed behaviour and adaptation to environmental changes or demands - in MS
are rare, even though impairments in a broad range of executive functions have
been observed (Arnett et al., 1994; Parmenter, Zivadinov, et al., 2007). Fifteen
to 20% of patients suffer from impaired executive dysfunction (Drew, Tippett,
Starkey, & Isler, 2008). Substantial deficits have been shown by Foong and col-
leagues (1997) in verbal fluency, interference, cognitive estimation, spatial working
memory, generating strategies and planning. Furthermore, executive deficits were
reported in semantic encoding and planning (Arnett et al., 1997) as well as in
inhibition and set shifting (Drew et al., 2008). Henry and Beatty (2006) conclude
that measures of fluency are amongst the most sensitive markers of cognitive im-
pairment in MS.
However, not all cognitive domains are affected in MS. General intellectual func-
tions (Macniven et al., 2008) and basic language skills such as word naming or
verbal comprehension are often spared, even in the advanced stages of the disease
(Rogers & Panegyres, 2007; Chiaravalloti & DeLuca, 2008). Also, simple attention
skills (e.g. repeating digits) are typically unaffected.
2.5.2 Neuropsychological assessment in MS
A formal neuropsychological assessment is time consuming and expensive, however,
cognitive deficits are not observable in routine neurological examinations and often
hidden by more visible deficit (e.g. motor or sensory symptoms). Offering only a
rough estimate of cognitive function (Rocca et al., 2015), cognitive function assess-
ment in the context of the EDSS is not sufficient to specify cognitive impairment
in patients with MS (Achiron et al., 2005). Other widely used screening meth-
ods for cognitive function, such as the Mini Mental State Examination (Marrie
& Goldman, 2007) or the Multiple Sclerosis Neuropsychological Screening Ques-
tionnaire (Benedict et al., 2003) are insensitive to the cognitive profile of patients
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with MS (Rocca et al., 2015). Furthermore, self-reported cognitive complaints are
often confounded by mood and other subjective symptoms (Benedict & Zivadi-
nov, 2011). Two validated cognitive test batteries have wide acceptance: the 45
min Brief Repeatable Battery of neuropsychological tests (Rao, 1991) and the 90
min Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS)
(Benedict, Cookfair, et al., 2006b). The Brief International Cognitive Assessment
for Multiple Sclerosis (BICAMS) (Langdon et al., 2012) has been lately developed
and represents a short cognitive assessment (15min) for patients with MS, which
is optimized for small centers with teams, which might not have training in neu-
ropsychological tests. However, there is a need for the identification of additional
neuropsychological assessment tools, which are particularly sensitive to MS-related
cognitive deficits, are needed.
Apart from the cognitive abilities it is recommended to appropriately assess fac-
tors that potentially confound the interpretation of the neuropsychological data,
including premorbid ability, fatigue and depression (Benedict et al., 2002). More-
over, sensory (e.g. visual) and motor disabilities as well as medication can lead to
misinterpretation of cognitive performance and should therefore be accounted.
2.6 Neuroanatomical correlates of cognition
In the last three decades, many studies have tried to demonstrate an association
between WM pathology and cognitive impairment. There was no doubt that fiber
integrity in the WM, which is interconnecting association cortices, is essential
for cognitive functioning. As a consequence, many studies aimed at correlating
cognitive impairment WM matter lesion load/volume or at identifying specific
locations of WM lesions and selective cognitive performance. For example, the
disruption of WM tracts has long been regarded as an explanation for the slowed
information processing speed. However, many researchers failed to make a clear
conclusion regarding the interaction of WM lesions and cognitive performance
(Foong et al., 1999; Franklin et al., 1989; Rao, Leo, Haughton, St Aubin-Faubert,
& Bernardin, 1989; Swirsky-Sacchetti et al., 1992), concluding the severity of cog-
nitive impairment in MS cannot be explained by WM lesions completely. The fact
that the association between common neuroradiological markers (e.g. T2 lesion
load) and clinical disability is weak is referred to as the ’clinico-radiological para-
dox’ (Barkhof, 2002).
Recent technical developments have led to a further clarification of cognitive im-
pairment in MS, highlighting the contribution of cortical lesions to cognitive im-
pairment. Significant correlation between total cortical lesion load and global
cognitive impairment index were found in a cross-sectional and longitudinal study.
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In the former, cognitively impaired MS patients showed more cortical lesions and
a higher cortical lesion volume than patients, which were cognitively preserved
(M. Calabrese et al., 2009). In the longitudinal study, a high baseline volume
of cortical lesions predicted worsening of cognitive performance (M. Calabrese et
al., 2012). Only few studies assessed the association between lesion location and
function. For instance, accumulation of cortical lesions in mesio-temporal areas is
associated with impairments in episodic memory (Roosendaal et al., 2009).
Compared to lesion load, MRI markers of atrophy such as increased third ven-
tricle width or reduced total white and grey matter volumes appear to be even
more closely linked to cognitive decline and are consistently found to correlate
more strongly with cognitive deficits (Sanfilipo, Benedict, Weinstock-Guttman, &
Bakshi, 2006; Zivadinov et al., 2001). This is particularly true for the TVW, which
is considered the best single MRI predictor for MS-related cognitive impairment
(Benedict, Bruce, et al., 2006; Benedict et al., 2004). However, also global white
and grey matter atrophy is related with multitude of cognitive impairment such as
deficits in processing speed and working memory (Tekok-Kilic et al., 2007), verbal
and nonverbal episodic memory (Benedict, Bruce, et al., 2006; Deluca et al., 2013),
or decision making (Radomski et al., 2015). Furthermore, Calabrese and colleagues
(2010) identified different patterns of cortical thickness in MS patients with and
without cognitive impairment. Only a limited number of studies have assessed
the association of regional brain atrophy and more specific cognitive impairment:
For instance, bilateral hippocampal atrophy has been related to lowered episodic
memory performance (Benedict, Ramasamy, Munschauer, Weinstock-Guttman, &
Zivadinov, 2009), and focal cortical thinning in the bilateral fusiform gyrus to im-
paired processing of facial expression (Mike et al., 2013). In a very recent study,
larger cortical volume in the supramarginal and superior temporal region of the
right hemisphere was associated with visuo-spatial memory, and verbal memory to
a larger cortical surface area in the lateral occipital, fusiform and inferior temporal
region (Nygaard et al., 2015).

3 Aims
The rationale of the present work is to contribute to a better understanding of the
underlying neural, in particular cortical structures responsible for the cognitive
impairment in patients suffering from MS. The motivation for this main aim is
based on previous research investigating the neuronal underpinnings of cognitive
impairment in MS patients, which still shows a inconsistent and incomplete image.
Furthermore, cognitive functioning is essential for being part of our - achievement
and efficiency-oriented - society. Thus, with a better understanding of the respon-
sible neural structures of cognitive functioning in MS, new prevention and therapy
guidelines can be developed.
By reviewing the pertinent research of neural correlates of cognitive impairment,
three research gaps emerged. Although the clinical importance of cortical pathol-
ogy has been shown in the recent years, studies investigating its association to
cognitive functioning are insufficient and many open questions are remaining. Sec-
ond, despite the increasing amount of correlational studies between neuroanatom-
ical alterations and broad defined cognitive dysfunction in MS, topological studies
on specific cognitive dysfunctions in MS are very rare. And third, despite the
identification of executive dysfunction in up to 20% of patients with MS and its
devastating effects on patients’ everyday life, studies examining these deficits are
rare, compared to studies on mnestic deficits or slowing in cognitive processing
speed. Moreover, random number generation, a test providing a sensitive measure
of frontal executive function (Baddeley, Emslie, Kolodny, & Duncan, 1998; Brug-
ger, Monsch, Salmon, & Butters, 1996), has never been applied in MS patients
and its anatomical correlates are unexplored.
Based on these gaps, the following research questions arose:
1. Do patients with and without cortical lesions differ regarding cognitive, de-
mographical and neurostructural characteristics?
2. What are the global and topological neural underpinnings of executive dys-
function in MS patients?
3. Is the randomization performance in MS patients different than the one from
healthy controls and what are the neuroanatomical correlates of randomiza-
tion performance?
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This dissertation, which aligned a cross-sectional study design and used the meth-
ods of structural MRI, includes three studies, which try to give an answers to the
above mentioned three research questions (Chapter 5). The first study focussed
on the differences of disease-characteristc patterns between MS patients with and
without DIR-hyperintense cortex-involving lesions. The second and the third study
focussed more on specific cognitive issues, namely on executive dysfunctions in MS.
Thus, whereas in the second study, global and topological correlates of executive
dysfunctions in MS patients were investigated, the third study examined - for the
first time - the performance of MS patients in a random generation task.
4 Methods
This section refers to the methods used in the three studies included in this disser-
tation. A brief overview is given here, whereas further details on the study-specific
samples and methods will be discussed in the empirical part (Chapter 5).
4.1 Participants
The study samples of the three studies are based on the same sample of subjects.
Fifty-one patients with a definite diagnosis of MS according to the McDonald
2010 criteria (Polman et al., 2011) and the most frequent, relapsing-remitting
course were recruited at the Multiple Sclerosis Centre of the University Hospital
of Zurich. Three patients had to be excluded from further analyses due to big
lesion load causing problems in the brain tissue segmentation. Furthermore, 48
age-, gender-, handedness-, and education-matched healthy controls (HC) with-
out previous or present history of neurological or psychiatric dysfunction were
included. All participants had to satisfy the following inclusion criteria: native
german speaker (Swiss German or other variant), minimal education of an ap-
prenticeship and no current or past substance abuse. Furthermore, based on most
recent clinical reports and subjective complaints, the following exclusion criteria
for the patient group were applied: a) relapse or steroid-treatment during the last
two months, b) current or past neurological disorder in addition to MS, c) psychi-
atric disorder apart from MS-related depressive mood state, d) a reading-relevant
visual acuity deficit, and e) a writing- and/or drawing-relevant upper limb sensori-
motor impairment of the dominant hand. Forty-seven patients (98%) were treated
with an immunomodulatory drug - 32 with natalizumab (67%), ten with beta-
interferon (21%), three with fingolimod (6%), one with glatiramer acetat (2%),
one with dimethylfumarat (2%) and one patient had no disease-modifying therapy
(2%). Control participants received financial compensation for their attendance.
Table 4.1 gives an overview of the two groups.
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Table 4.1: Demographics of the patient and the control group
Control MS t Z χ2 p
group group
N 48 48
Age M = 38.02 M = 38.79 .398 .691
SD = 9.6 SD = 9.3
Range = 21-57 Range = 18-58
Years of Education M = 14.58 M = 14.44 -.846 .398
(years) SD = 2.5 SD = 3.05
Range = 11-20 Range = 11-22
Sex .00 1.00
female 37 37
male 11 11
Handedness .447 .506
left 6 4
right 42 44
Note. Two-tailed tests.
4.2 Cognitive assessment
An extensive battery of neuropsychological tests, lasting about two hours, was
administered to each subject, assessing a variety of cognitive functions such as
executive functions, attention, learning and memory, visuospatial functions and
premorbid intelligence. The selection of tests is based on psychometric properties
and on recommendations regarding the cognitive domains that should be examined
in MS patients (Benedict et al., 2004). Except of one (Mental Dice Task), all
tests are standardized, validated and provide age-related norms. Additionally,
three questionnaires were used to evaluate self-reported fatigue, depression and
quality of life. Table 4.2 gives an overview of the neuropsychological tests and the
questionnaires.
4.2 Cognitive assessment 21
T
a
bl
e
4
.2
:
N
eu
ro
p
sy
ch
ol
og
ic
al
te
st
s
a
n
d
q
u
es
ti
o
n
n
a
ir
es
in
cl
u
d
ed
in
th
e
n
eu
ro
p
sy
ch
o
lo
g
ic
a
l
ex
a
m
in
a
ti
o
n
.
N
e
u
r
o
p
sy
c
h
o
lo
g
ic
a
l
N
e
u
r
o
p
sy
c
h
o
lo
g
ic
a
l
te
st
N
o
r
m
.
R
e
fe
r
e
n
c
e
fu
n
c
ti
o
n
N
=
E
x
e
c
u
ti
v
e
fu
n
c
ti
o
n
s
W
o
rk
in
g
m
em
o
ry
T
es
ts
o
f
A
tt
en
ti
o
n
a
l
P
er
fo
rm
a
n
ce
,
w
o
rk
in
g
m
em
o
ry
,
le
v
el
3
3
2
2
Z
im
m
er
m
a
n
n
a
n
d
F
im
m
(2
0
0
7
)
V
er
b
a
l
fl
u
en
cy
R
eg
en
sb
u
rg
er
v
er
b
a
l
fl
u
en
cy
te
st
6
3
4
A
sc
h
en
b
re
n
n
er
,
T
u
ch
a
,
a
n
d
L
a
n
g
e
(2
0
0
0
)
D
es
ig
n
fl
u
en
cy
H
A
M
A
S
C
H
-5
-p
o
in
t
te
st
1
8
4
H
a
id
et
a
l.
(2
0
0
2
)
In
te
rf
er
en
ce
co
n
tr
o
l
D
el
is
-K
a
p
la
n
E
x
ec
u
ti
v
e
F
u
n
ct
io
n
S
y
st
em
,
co
lo
u
r-
w
o
rd
in
te
rf
er
en
ce
co
n
d
it
io
n
1
7
5
0
D
el
is
,
K
a
p
la
n
,
a
n
d
K
ra
m
er
(2
0
0
1
)
C
o
g
n
it
iv
e
fl
ex
ib
il
it
y
D
el
is
-K
a
p
la
n
E
x
ec
u
ti
v
e
F
u
n
ct
io
n
S
y
st
em
,
co
lo
u
r-
w
o
rd
se
t-
sh
if
ti
n
g
co
n
d
it
io
n
1
7
5
0
D
el
is
et
a
l.
(2
0
0
1
)
C
o
g
n
it
iv
e
fl
ex
ib
il
it
y
/
M
en
ta
l
D
ic
e
T
a
sk
B
ru
g
g
er
,
M
il
ic
ev
ic
,
R
eg
a
rd
,
a
n
d
C
o
o
k
(1
9
9
3
)
R
a
n
d
o
m
iz
a
ti
o
n
p
er
fo
rm
a
n
ce
A
tt
e
n
ti
o
n
a
l
fu
n
c
ti
o
n
s
A
le
rt
n
es
s
(t
o
n
ic
&
p
h
a
si
c)
T
es
ts
o
f
A
tt
en
ti
o
n
a
l
P
er
fo
rm
a
n
ce
,
a
le
rt
n
es
s
6
0
4
Z
im
m
er
m
a
n
n
a
n
d
F
im
m
(2
0
0
7
)
S
el
ec
ti
v
e
A
le
rt
n
es
s
T
es
ts
o
f
A
tt
en
ti
o
n
a
l
P
er
fo
rm
a
n
ce
,
G
o
/
N
o
G
o
4
1
7
Z
im
m
er
m
a
n
n
a
n
d
F
im
m
(2
0
0
7
)
In
fo
rm
a
ti
o
n
p
ro
ce
ss
in
g
sp
ee
d
D
el
is
-K
a
p
la
n
E
x
ec
u
ti
v
e
F
u
n
ct
io
n
S
y
st
em
,
co
lo
u
r
n
a
m
in
g
co
n
d
i-
ti
o
n
/
w
o
rd
re
a
d
in
g
te
st
(r
ea
d
&
co
lo
u
r
co
n
d
it
io
n
)
1
7
5
0
D
el
is
et
a
l.
(2
0
0
1
)
L
e
a
r
n
in
g
&
m
e
m
o
r
y
V
er
b
a
l
m
em
o
ry
sp
a
n
W
ec
h
sl
er
M
em
o
ry
S
ca
le
-
re
v
is
ed
,
v
er
b
a
l
sp
a
n
2
0
1
H
a¨
rt
in
g
et
a
l.
(2
0
0
0
)
V
is
u
a
l
m
em
o
ry
sp
a
n
W
ec
h
sl
er
M
em
o
ry
S
ca
le
-
re
v
is
ed
,
v
is
u
a
l
sp
a
n
2
0
1
H
a¨
rt
in
g
et
a
l.
(2
0
0
0
)
V
er
b
a
l
le
a
rn
in
g
V
er
b
a
l
le
a
rn
in
g
m
em
o
ry
te
st
,
fi
v
e
le
a
rn
in
g
tr
ia
ls
5
0
0
H
el
m
st
a
ed
te
r,
L
en
d
t,
a
n
d
L
u
x
(2
0
0
1
)
V
er
b
a
l
re
ca
ll
V
er
b
a
l
le
a
rn
in
g
m
em
o
ry
te
st
,
sh
o
rt
a
n
d
lo
n
g
d
el
a
y
fr
ee
re
ca
ll
5
0
0
H
el
m
st
a
ed
te
r
et
a
l.
(2
0
0
1
)
V
er
b
a
l
re
co
g
n
it
io
n
V
er
b
a
l
le
a
rn
in
g
m
em
o
ry
te
st
5
0
0
H
el
m
st
a
ed
te
r
et
a
l.
(2
0
0
1
)
V
is
u
a
l
re
ca
ll
R
ey
C
o
m
p
le
x
F
ig
u
re
T
es
t,
sh
o
rt
&
lo
n
g
d
el
a
y
fr
ee
re
ca
ll
6
0
1
M
ey
er
s
a
n
d
M
ey
er
s
(1
9
9
5
)
V
is
u
a
l
re
co
g
n
it
io
n
R
ey
C
o
m
p
le
x
F
ig
u
re
T
es
t,
re
co
g
n
it
io
n
6
0
1
M
ey
er
s
a
n
d
M
ey
er
s
(1
9
9
5
)
V
is
u
o
c
o
n
st
r
u
c
ti
v
e
fu
n
c
ti
o
n
s
V
is
u
o
sp
a
ti
a
l
&
-c
o
n
st
ru
ct
iv
e
p
er
fo
r-
m
a
n
ce
R
ey
C
o
m
p
le
x
F
ig
u
re
T
es
t,
co
p
y
6
0
1
M
ey
er
s
a
n
d
M
ey
er
s
(1
9
9
5
)
C
o
g
n
it
iv
e
r
e
se
r
v
e
P
re
m
o
rb
id
in
te
ll
ec
tu
a
l
le
v
el
V
er
b
a
l
sh
o
rt
in
te
ll
ig
en
ce
te
st
1
1
1
7
A
n
g
er
,
M
er
te
sd
o
rf
,
W
eg
n
er
,
a
n
d
W
u¨
lfi
n
g
(1
9
9
8
)
P
re
m
o
rb
id
in
te
ll
ec
tu
a
l
le
v
el
M
u
lt
ip
le
C
h
o
ic
e
W
o
rd
T
es
t-
B
1
9
5
2
L
eh
rl
(2
0
0
5
)
Q
u
e
st
io
n
n
a
ir
e
s
D
ep
re
ss
io
n
G
en
er
a
l
D
ep
re
ss
io
n
S
ca
le
1
2
9
8
H
a
u
tz
in
g
er
a
n
d
B
a
il
er
(1
9
9
2
)
P
h
y
si
ca
l
a
n
d
co
g
n
it
iv
e
fa
ti
g
u
e
W
u¨
rz
b
u
rg
er
F
a
ti
g
u
e
In
v
en
to
ry
fo
r
M
S
1
6
1
F
la
ch
en
ec
k
er
,
K
o¨
n
ig
,
M
ei
ss
n
er
,
a
n
d
M
u¨
ll
er
(2
0
0
8
)
Q
u
a
li
ty
o
f
li
fe
S
h
o
rt
F
o
rm
H
ea
lt
h
S
u
rv
ey
Q
u
es
ti
o
n
n
a
ir
e
2
9
1
4
B
u
ll
in
g
er
a
n
d
K
ir
ch
b
er
g
er
(1
9
9
8
)
22 Methods
4.3 Volumetric MR Imaging
A number of computer-assisted post-processing techniques for measuring white
and grey matter MS lesion load as well as brain atrophy have been developed to
provide quantitative means for determining the extent of disease abnormality. In
the following sections, the technique to quantify lesion load and several atrophy
parameters will be introduced shortly.
4.3.1 How to quantify lesion load in Multiple Sclerosis?
Quantitative characterization of MS lesion load is of central importance to clinical
studies investigating the impact of lesions on cognitive or physical abilities. Many
manual, semi-automated and automated segmentation techniques have been pro-
posed to quantify total lesion volume as well as the total number of lesions (Llado´
et al., 2012). Despite recent technical progress, due to the heterogeneous intensities
among different MRI images, automated segmentation of MS lesions is a challeng-
ing task. Fully automated methods are often error prone and less accurate than
the manual segmentation of MS lesion. The latter, in contrast, is known to be
time-consuming and shows a high inter-oberserver variability (Llado´ et al., 2012).
There is not yet a specific automated lesion segmentation approach robust enough
to emerge as a standard for clinical and research practice. Thus, in order to quan-
tify the lesion volume in the studies included in this thesis, the lesions were manu-
ally delineated with MRIcron (http://sph.sc.edu/comd/rorden/mricron). Once all
visible lesions of each patient were marked on individual three-dimensional scans,
the total lesion volume and number was extracted and used for further analy-
ses. In order to perform topological lesion analyses, normalization of the individ-
ual brains to the standard space of Montreal Neurological Institute with SPM8
(http://www.fil.ion.ucl.ac.uk/spm) was needed. The normalized lesion plots were
then mapped on a template brain with MRIcron to create lesion overlap plots.
MRIcron comprises a non-parametric mapping (NPM) software, which allows topo-
logical analyses and which is designed to relate lesion location to behavioral per-
formance (Rorden, Karnath, & Bonilha, 2007). With this voxelbased approach, it
is possible to elucidate structure-function relationships. Thus, in order to calculate
the relationship between the location of the lesions and the behavioral performance
voxel-based lesion symptom mapping (VLSM) was performed, which is a voxel-
based statistical method that allows a correlation between behavioural measures
and lesions on a voxel-by-voxel basis (Kimberg, Coslett, & Schwartz, 2007). VLSM
was performed in Study 2.
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4.3.2 Brain atrophy
In addition to lesions, atrophy is another imaging hallmark of MS. The improve-
ment in post-processing methods allows to quantify the extent of tissue loss in
white and grey matter as well as the distribution of atrophy at a regional level.
Thus, beside the quantification of lesion load, central, whole-brain and cortical
atrophy were assessed.
Whole-brain atrophy
Brain parenchymal fraction (BPF) was used as a normalized measurement of
whole-brain atrophy. BPF was calculated as the ration of brain parenchymal tis-
sue volume to the total volume contained within the brain surface contour (total
intracranial volume). The calculation was performed with Jim software (Xinapse
Systems Ltd., Northants (UK); http://www.xinapse.com).
Central atrophy
To assess central atrophy, third ventricular width was measured from the FLAIR
images by applying the procedure specified by Benedict and colleagues (2006).
Accordingly, a line was drawn through the long axis of the third ventricle parallel
to the interhemispheric fissure, where the ventricle was most visible. Then a second
line, perpendicular to the first one, was drawn through the midpoint of the first
line in order to measure (in millimeters) the width of ventricle, which was further
used for the statistical analyses. The calculation was performed with Jim software
(Xinapse Systems Ltd., Northants (UK); http://www.xinapse.com).
Cortical atrophy
Cortical thickness evaluation - representing a measurement of cortical atrophy -
was performed by means of Freesurfer image analysis suite, which is documented
and freely available online (http://surfer.nmr.mgh.harvard.edu). The procedure
for the measurement of cortical thickness by Freesurfer has been validated against
histological analysis (Rosas et al., 2002) and manual measurements (Kuperberg et
al., 2003). For technical details of the analysis pipeline I refer to prior publications
validating and describing the procedure (Dale & Sereno, 1993; Dale, Fischl, &
Sereno, 1999; Fischl & Dale, 2000), as it would go beyond the scope of this thesis.
However, a short summary is given here: The cortical thickness is defined as the
shortest distance between the pial (the border between GM and CSF) and the
white matter (the interface between white and grey matter) surface (Figure 4.1).
Freesurfer’s surface-based analysis (SBM) reconstructs models of the two surfaces
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Figure 4.1: Brain with the two models of the pial (red) and white matter (yellow) surfaces,
reconstructed by Freesurfer.
in each subject’s native space by a set of automated tools. Briefly, this processing
includes removal of non-brain tissue, registration to the Talairach space, intensity
normalization and tessellation. Furthermore, the surfaces can be parcellated into
gyral and sulcal regions of interest (Desikan et al., 2006). Once these surfaces are
known, the evaluation of cortical thickness at each point on the cortex becomes
possible. Metrics resulting from this approach are fairly straightforward to inter-
pret, as they clearly represent a geometrical property of the cortex and are stated
in standard units (e.g. cortical thickness in mm), which makes statistical interpre-
tation easy. In order to do group analyses, a nonrigid high-dimensional spherical
averaging over all patients, respectively controls was needed. With this method, it
is possible to accurately match morphological homologous cortical locations among
participants. A cortical surface-based atlas is defined, which is based on average
folding pattern of all subjects mapped to a sphere. Thus, the surfaces from indi-
viduals can be aligned with this atlas, providing a point-to-point correspondence
between the subjects. Once all surfaces are registered onto a standard template
surface, vertex-wise analyses can be done.
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This doctoral thesis is based on three first authorship articles:
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Cortical thinning in the anterior cingulate cortex predicts Multiple Sclerosis pa-
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teristics and neural correlates
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5.1.1 Abstract
Background : Recent studies suggest that cortical lesions in multiple sclerosis (MS)
substantially contribute to clinical disease severity. The present study aimed at
investigating clinical, neuroanatomical, and cognitive correlates of these cortical
lesions with a novel approach, i.e. by comparing two samples of relapsing-remitting
multiple sclerosis (RRMS) patients, one group with and the other without cortical
lesions.
Methods : High-resolution structural MRI was acquired from 42 RRMS patients
and 43 controls (HC). The patient group was dichotomized based on the presence
versus absence of DIR-hyperintense cortex-involving lesions, resulting in a cortical
lesion group (CL, n = 32) and a non-cortical lesion group (nCL, n =10). Cognitive
functioning was assessed in all participants with a comprehensive neuropsycholog-
ical battery, covering mnestic, executive, and attentional functions.
Results : Highest densities of cortical lesions in the CL group were observed in the
bilateral parahippocampal gyrus. Relative to HC, patients with cortical lesions
- but not those without - showed significant global cortical thinning and mnestic
deficits. The two patient groups did not differ from each other regarding demo-
graphic and basic disease characteristics such as EDSS scores.
Conclusion: The appearance of cortical lesions in MS patients is associated with
cortical thinning as well as mnestic deficits, which might be key characteristics of
a ’cortically dominant’ MS subtype.
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5.1.2 Background
First histological reports of demyelinated foci in the cerebral cortex of patients with
multiple sclerosis (MS) date back to the beginning of the 20th century (Dawson,
1916). However, the classical view of MS as a pure white matter pathology has not
been overcome until the beginning of the 21st century. Due to the introduction of
more sensitive imaging techniques such as double inversion recovery (DIR), gray
matter involvement in the pathology of multiple sclerosis is now well established
(Geurts & Barkhof, 2008; M. Calabrese, Magliozzi, et al., 2015). However, enthu-
siasm for the use of DIR was somewhat decreased by the observation that it still
can only detect a minority of cortical lesions in MS, when directly compared with
post-mortem histopathological findings (Seewann et al., 2012).
With regard to the functional relevance of cortical MS lesions, cross-sectional
studies have shown that lesion number and volume are associated with physical
(M. Calabrese et al., 2007) and cognitive impairment (M. Calabrese et al., 2009;
Mike et al., 2011). However, these studies are not without limitations. For exam-
ple, detailed cognitive investigation (M. Calabrese et al., 2009) or DIR sequences
were lacking (Mike et al., 2011). The present study was aimed at investigating the
clinical relevance of cortical lesions with a novel methodological approach, i.e. by
dichotomizing patients based on the presence or absence of cortical lesions. The
resulting two subgroups were compared with regard to demography, cognition,
fatigue, affective mood state, and several other established MRI markers of dis-
ease severity, for example T2 lesion load, third ventricle width, and global cortical
thinning.
5.1.3 Methods
Participants
Forty-two patients with a diagnosis of relapsing-remitting multiple sclerosis (RRMS)
according to the McDonald 2010 criteria (Polman et al., 2011) were recruited at
the Multiple Sclerosis Centre of the University Hospital of Zurich. Patients with
at least one DIR-hyperintense cortex-involving lesion were assigned to the cortical
lesion group (CL group, n = 32), the remaining patients formed the non-cortical
lesion group (nCL group, n = 10). All patients received immunomodulatory treat-
ment - 30 with natalizumab, seven with beta-interferons, three with fingolimod,
one with glatiramer acetat and one with dimethylfumarate. Exclusion criteria were
a relapse or steroid-treatment during the last two months, current or past neuro-
logical disorder in addition to multiple sclerosis, and psychiatric disorders apart
from a MS-related depressive mood state. Moreover, none of the patients was af-
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fected by severe visual deficits or upper limb sensorimotor impairment that could
hinder cognitive test performance. Furthermore, 43 age-, gender-, handedness-
and education-matched healthy control persons (HC) without previous or present
history of neurological or psychiatric diseases were included. Controls received
financial compensation for their attendance. The study was approved by the local
Ethical Committee, and written informed consent was obtained from all subjects.
MRI data acquisition
The MR scan was performed within one month of the neurological and neuropsy-
chological examinations. All images were acquired using a 1.5-T scanner (Siemens
Magnetom AvantoTM) equipped with a SQ-engine gradient (45m/T/m @ 200
T/m/s) using a dedicated 32-channel head coil. No hardware upgrades of the
scanner occurred during the study period. The following sequences were obtained
from all subjects: (1) 3D Double Inversion Recovery sequence (DIR) (voxel size
=1.5 x 1.5 x 1.5 mm, slice thickness = 1.5 mm, repetition time = 7500ms, echo
time = 308ms); (2) 3D T1-weighted MPRAGE (voxel size = 1 x 1 x 1 mm, slice
thickness = 1 mm, repetition time = 2420 ms, echo time = 4.18 ms) and (3) a 3D
FLAIR (voxel size = 0.9 x 0.9 x 2.0 mm, slice thickness = 2 mm, repetition time
= 5000 ms, echo time = 342 ms).
MRI post-processing and statistical analysis
The classification of cortical lesions was conducted according to the consensus
recommendations of Geurts and colleagues (Geurts et al., 2011). Consequently,
cortical lesions were defined as those lesions appearing hyperintense on DIR images
compared to surrounding normal-appearing gray matter, entirely or partly located
in the cortical gray matter and occupying at least three voxels. Juxtacortical le-
sions (lesions not entering, but neighboring the cortical mantle) were not scored.
DIR-hyperintense lesions were identified and manually delineated with MRIcron
(http://sph.sc.edu/comd/rorden/mricron), which was further used to measure to-
tal cortical lesion volume. An experienced rater, supervised by a neuroradiologist,
assessed all images. The same procedure was applied to FLAIR images in order
to identify FLAIR-hyperintense lesions. We used Statistical Parametric Mapping
(SPM8, http://www.fil.ion.ucl.ac.uk/spm/) to co-register and normalize the in-
dividual lesion maps to MNI (Montreal Neurological Institute) standard space.
Normalized lesions were then mapped with MRIcron on a template brain to create
lesion overlap plots. Central brain atrophy was examined by measuring the width
of the third ventricle (TVW) according to the procedure proposed by Benedict
and colleagues (Benedict, Bruce, et al., 2006). Brain parenchymal fraction (BPF),
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calculated as the ratio of brain parenchymal tissue volume to the total intracra-
nial volume, was used as a measurement of whole-brain atrophy. Cortical thick-
ness evaluation was performed with the semi-automated Freesurfer image analysis
suite based on MPRAGE images, which is documented and freely available online
(http://surfer.nmr.mgh.harvward.edu). Further information and technical details
of these procedures are described in prior publications (Fischl, Sereno, & Dale,
1999; Dale et al., 1999). To detect possible misclassifications of white and gray
matter due to multiple sclerosis lesions, all images were visually inspected after the
white/gray matter segmentation. In two patients, a semi-automated correction of
topological defects was required. We used the manual procedure of control points,
which is implemented in the Freesurfer software package.
Clinical and neuropsychological assessment
All patients underwent neurological status examination, including a rating of the
Expanded Disability Status Scale (EDSS). Cognitive functions were assessed with
a comprehensive battery of validated and standardized neuropsychological tests.
To minimize the issue of multiple statistical testing, composite index scores were
computed for mnestic, executive and attentional functions by averaging z-scores
for all subtests of the corresponding function (La Joie et al., 2014). An overview
of the indices is shown in supplemental Table 5.2 (see Supplemental material in
Section 5.1.7). The mnestic index score was derived from the delayed free recall
and recognition of a 15-item word list (Helmstaedter et al., 2001) as well as the
delayed free recall and recognition of a previously copied complex geometric fig-
ure (Meyers & Meyers, 1995). Phonemic-verbal (Aschenbrenner et al., 2000) and
figural fluency (Haid et al., 2002), response inhibition (Delis et al., 2001) and cog-
nitive flexibility (Delis et al., 2001) formed the executive index. The attentional
index was based on processing speed during color naming (Delis et al., 2001) as
well as on reaction times from tasks measuring alertness and selective attention
(Zimmermann & Fimm, 2007). Moreover, participants had to complete a Ger-
man version (Hautzinger & Bailer, 1992) of the CES-D Depression questionnaire
(Radloff, 1977) and the Wu¨rzburg Fatigue Inventory (WEIMuS) (Flachenecker et
al., 2008) to self-rate depressive symptoms as well as fatigue during the last week.
Similar to other studies (Sumowski et al., 2014), cognitive reserve was examined
with vocabulary knowledge (multiple choice word test) (Lehrl, 2005).
Statistical analysis
Statistical analyses were performed with SPSS (IBM, Chicago, USA, Version, 21.0,
http://spss.com). Unless otherwise stated, a p-level below 5% was considered
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Table 5.1: Demographic and disease characteristics of multiple sclerosis patients
and healthy controls.
nCL group CL group Controls Test p-value
(n = 10) (n = 32) (n = 43)
Mean (SD) Mean (SD) Mean (SD)
Age, years 32.6 (9.98) 38.22 (7.2) 36.1 (8.29) ANOVA 0.155
Education, years 15.5 (3.1) 14.45 (3.2) 14.58 (2.4) KW 0.408
EDSS 2.0 (1.8) 2.8 (1.8) - MW-U 0.174
Age at diagnosis, years 26.7 (9.7) 30.65 (7.6) - t-test 0.185
Disease duration, years 65.5 (59.6) 85.31 (68.9) - MW-U 0.570
Abbreviations: nCL = patients without cortical lesions; CL = patients with cortical
lesions; one-way ANOVA = one-way analysis of variance; EDSS = Expanded Disability
Status Scale; KW = Kruskal-Wallis; MW-U = Mann-Whitney U
statistically significant. Assumptions for normality were tested for all continuous
data with Kolmogorov-Smirnov tests. In case of normally distributed variables,
a multivariate ANOVA was used to compare groups. Bonferroni correction was
applied for post-hoc analyses. When variables were not normally distributed, non-
parametric tests were applied (Mann-Whitney U, Kruskal-Wallis).
5.1.4 Results
Demographic and clinical variables
Demographic and clinical characteristics of the three groups are reported in Table
5.1. No between-group differences were found with regard to age, education, and
gender. Furthermore, EDSS, age at diagnosis, and disease duration did not differ
significantly between CL and nCL patients.
MRI markers
We detected cortical lesions in 32 of 42 patients (76%). The highest occurrence of
cortical lesions was found bilaterally in the parahippocampal gyrus (Figure 5.1).
Twenty-five percent of the CL patients showed at least one cortical lesion in this
region.
An overview of the atrophy measurements of the three groups is given in Figure 5.2.
The three groups differed significantly from one another with regard to BPF (F(2)
= 22.4, p <0.001), TVW (H(2) = 20.9, p<0.001) and cortical thickness (F(2)
= 11.6, p<0.001). Bonferroni-corrected post-hoc analyses revealed a reduction
of BPF in CL patients relative to HC (p<0.001) as well as an enlarged TVW
(p<0.001). In contrast, the BPF and TVW values of nCL patients did not differ
from those of CL patients or controls. Furthermore, Bonferroni-corrected post-hoc
analyses revealed a reduction of global cortical thickness in CL patients compared
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to HC (p<0.001) and nCL (p = 0.029) patients, while HC and nCL patients did
not differ from one another. Regarding the FLAIR-hyperintense lesion volume no
significant difference (p = 0.064) was observed between the two patient groups.
Cognitive test results, fatigue and depression questionnaires
The attentional index did not differ between the three groups (F(2) = 1.207, p
= 0.304). In contrast, a group effect was observed for the executive index (H(2)
= 22.476, p<0.001). Both patient groups showed executive dysfunction compared
to HC (CL vs. HC: Z(2) = -4.272, p<0.001; nCL vs. HC: Z(2) = -3.197, p ¡
0.001), but did not differ from one another (Z(2) = -0.251, p = 0.805). Further-
more, there was a main group effect for mnestic functions (F(2) = 7.667, p<0.001).
Bonferroni-corrected post-hoc analyses revealed that the CL group performed sig-
nificantly worse in memory tests than the nCL (p = 0.031) as well as the HC group
(p<0.001), whereas the nCL patients did not differ from the HC in this regard.
Figure 5.3 depicts the three cognitive indices and corresponding differences be-
tween groups. According to supplemental analyses (summarized in supplemental
Table 5.3, see Supplemental material in Section 5.1.7) of the individual subtests of
the indices, differences between the patient groups were most strongly pronounced
in figural recognition. No main group effect was seen for depression (H(2) = 5.634,
p = 0.060), but both patient groups showed significantly elevated fatigue scores
compared with HC (CL vs. HC: Z(2) = -2.319, p = 0.020; nCL vs. HC: Z(2)
= -2.102, p = 0.036), but did not differ from one another in this regard (Z(2) =
-0.445, p = 0.673).
5.1.5 Discussion
The impact of gray matter pathology, in particular that of gray matter lesions,
on cognitive and physical functioning in MS patients has been discussed for many
years. Here we highlight the clinical relevance of DIR-hyperintense cortical lesions
in patients with RRMS. The most intriguing finding of the present study was that
patients with - compared to those without visible cortical lesions - differed from
each other in global cortical thickness and mnestic functions, whereas no differ-
ences between these two patient groups were observed regarding EDSS, age, age at
diagnosis, disease duration, or non-mnestic cognitive functions. Moreover, patients
without cortical lesions showed normal cortical thickness and mnestic functions,
when compared with a group of healthy controls. That a reduction of cortical
thickness can occur in MS (e.g. Sailer et al., 2003)- and that this thinning is re-
lated to global (e.g. M. Calabrese, Rinaldi, et al., 2010) and even specific cognitive
impairment (Mike et al., 2013; Geisseler et al., 2016) - has been found in previous
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Figure 5.1: Spatial distribution of cortex-involving lesions in the CL patient group. Overlap
plot based on all normalized cortex-involving lesions found in all CL patients. Lesion frequency
across the sample is displayed for every depicted voxel. The bar indicates the number of patients
showing damage to a particular voxel. A) Axial and coronal views of lesion frequency. B) and
C) Highest lesion overlap was found in the bilateral parahippocampal gyrus (MNI coordinates
in B). Image orientation follows the radiological convention (right on left side).
studies. Similar to a recent finding (M. Calabrese, Reynolds, et al., 2015), we show
an association between MS-related cortical thinning and the presence of cortical
MS lesions. It is known that gray matter pathology involves both inflammatory
and degenerative mechanisms, but the relationship between the two remains un-
clear (M. Calabrese, Magliozzi, et al., 2015). Gray matter atrophy might be the
final step of several pathological processes, which could include cortical demyeli-
nation but also retrograde degeneration secondary to white matter lesions and,
perhaps, primary neurodegeneration (Geurts et al., 2012).
We detected DIR-hyperintense cortical lesions in 76% of our RRMS patients, sup-
porting the notion of a high prevalence of these lesions (M. Calabrese et al., 2007).
In further agreement with previous findings (M. Calabrese, Favaretto, Martini, &
Gallo, 2013), we observed an uneven spatial distribution of cortical lesions over the
cerebral cortex, with a prominent accumulation in memory-relevant mesiotemporal
regions, particularly in the bilateral parahippocampal gyrus. While the importance
of the hippocampus for memory function is known since the classical description
of the patient H.M. in 1957 (Scoville & Milner, 1957), parahippocampal involve-
ment in memory functions was recognized only two decades ago (Zola-Morgan,
Squire, Amaral, & Suzuki, 1989). Squire and Zola-Morgen (1991) identified the
anatomical components of what is termed the medial temporal memory system.
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Figure 5.2: Bars depict mean z-scores (and standard errors) of patients with (CL) and without
cortex-involving (nCL) lesions as well as of healthy controls (HC). Note that the two patient
groups differed only in global cortical thickness.
By now it is well known that bilateral damage to the medial temporal lobe causes
severe learning and memory impairments. This relationship has also been shown
in MS patients. Learning and memory is the most frequently disrupted cognitive
domain in MS, reported in 40-60% of patients (Rogers & Panegyres, 2007). More-
over, Coebergh et al. (2010) described a patient with acute memory impairment,
associated with hippocampal and cortical lesions. Cortical lesions were also as-
sociated with cognitive decline in a group of 13 MS patients (Roosendaal et al.,
2009). In this study, a significant correlation between hippocampal lesion load and
visuospatial memory was observed. Based on the present and previous findings, we
thus conclude that mesiotemporal cortical lesions are highly prevalent in RRMS
patients and play a crucial role in the development of mnestic dysfunction.
The association we found between memory impairment and both cortical thin-
ning as well as cortical lesions seems particularly intriguing: One might speculate
that mnestic dysfunction in MS patients could indicate cortical involvement of the
MS pathology in general. Related to this assumption, a rarely occurring variant
of so-called ’cortical MS’ has been described in previous studies (Zarei, Chan-
dran, Compston, & Hodges, 2003; Zarei, 2006). The condition was characterized
by predominant presence of neurobehavioral symptoms (e.g. depression, apathy)
and neuropsychological deficits (e.g. agraphia, anomia) suggesting cortical dys-
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Figure 5.3: Bars show mean z-scores (and standard errors) of patients with (CL) and without
cortex-involving (nCL) lesions as well as of healthy controls (HC). Note that the two patient
groups differed only in mnestic functioning.
function. Our patient group with cortical involvement may reflect an incomplete
variant of such cortical MS, as they showed distinct mnestic deficits in associa-
tion with cortical involvement, but no other cortical symptoms such for example
depression. Moreover, we found no patient with cortical lesions in the absence of
subcortical lesions. In all patients, including those of the CL group, the majority
of MS lesions was located subcortically. Taking this into account, we here propose
that our CL group may represent a ’cortically dominant’ subtype of MS. In these
patients, pathophysiological processes might be different from those of patients
without cortical involvement.
Much research and clinical development in MS has focused on the inflammatory
mechanisms of the disease. Meanwhile, multiple disease-modifying drugs (DMD)
are available that target the inflammatory pathology of MS, in particular the de-
velopment of new white matter lesions (Barkhof, Calabresi, Miller, & Reingold,
2009). A recent study demonstrated that DMD - in particular IFN β -1a and
glatiramer acetate - can reduce the accumulation of cortical lesions too (Rinaldi
et al., 2015). In addition, Filippi and colleagues (Filippi et al., 2010) showed that
the presence of at least one cortical lesion is associated with a high risk of conver-
sion from clinically isolated syndrome (CIS) to definite MS within a short period.
Together with our results, these findings highlight the relevance of cortical lesions
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as a “target” in the development of new DMD, and to include cortical lesions as
a primary outcome variable in disease and treatment monitoring.
5.1.6 Conclusion
In conclusion, the occurrence of cortical lesions in MS is clinically relevant insofar
as it is associated with neurodegenerative cortical thinning and mnestic dysfunc-
tion. Although with today’s imaging techniques, it is only possible to visualize
the ’tip of the iceberg’ of cortical MS lesions (Seewann et al., 2012, 2011), fur-
ther progress in detection algorithms can be expected and will likely improve our
understanding of MS pathology, symptoms, and treatment.
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5.2.1 Abstract
Cognitive impairment is as an important feature of Multiple Sclerosis (MS), and
might be even more relevant to patients than mobility restrictions. Compared to
the multitude of studies investigating memory deficits or basic cognitive slowing,
executive dysfunction is a rarely studied cognitive domain in MS, and its neural
correlates remain largely unexplored. Even rarer are topological studies on spe-
cific cognitive functions in MS. Here we used several structural MRI parameters
– including cortical thinning and T2 lesion load – to investigate neural correlates
of executive dysfunction, both on a global and a regional level by means of voxel-
and vertex-wise analyses. Forty-eight patients with relapsing-remitting MS and
48 healthy controls participated in the study. Five executive functions were as-
sessed, i.e. verbal and figural fluency, working memory, interference control and
set shifting. Patients scored lower than controls in verbal and figural fluency only,
and displayed widespread cortical thinning. On a global level, cortical thickness
independently predicted verbal fluency performance, when controlling for lesion
volume and central brain atrophy estimates. On a regional level, cortical thin-
ning in the anterior cingulate region correlated with deficits in verbal and figural
fluency and did so in a lateralised manner: Left-sided thinning was related to re-
duced verbal – but not figural – fluency, whereas the opposite pattern was observed
for right- sided thinning. We conclude that executive dysfunction in MS patients
can specifically affect verbal and figural fluency. The observed lateralised clinico-
anatomical correlation has previously been described in brain-damaged patients
with large focal lesions only, for example after stroke. Based on focal grey matter
atrophy, we here show for the first time comparable lateralised findings in a white
matter disease with widespread pathology.
Keywords
Multiple sclerosis, executive function, fluency, atrophy, cortical thinning
Abbreviation
EDSS = expanded disability status scale; FDR = false discovery rate; FLAIR =
fluid attenuated inversion recovery; MPRAGE = magnetization prepared rapid
gradient-echo imaging; MS = multiple sclerosis; TVW = third ventricle width;
VLSM = voxel-lesion symptom mapping
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5.2.2 Introduction
Multiple Sclerosis (MS) is a chronic demyelinating disease affecting all parts of
the central nervous system. It used to be characterised primarily by its sensory,
motor and visual symptoms. However, cognitive impairment is now recognised
as an important feature of MS, prevalent in 43–70% of patients (Chiaravalloti &
DeLuca, 2008). It might even be more relevant to patients than mobility restric-
tions (Amato et al., 2006). As MS has usually an early onset in young adult life
(P. Calabrese, 2006), cognitive impairment significantly contributes to patients’
disability status, is critical for working capacity, and thus negatively affects qual-
ity of life (Rao, Leo, Ellington, et al., 1991). Processing speed and episodic memory
seem the most prominent cognitive features of MS (Chiaravalloti & DeLuca, 2008);
however, MS patients often exhibit significant deficits in executive functions too
(Drew et al., 2008). Although the latter can have devastating effects on patients’
everyday life, their level of independence and societal costs (Amato et al., 2013),
studies examining executive deficits in MS patients are rare (Foong et al., 1999;
Henry & Beatty, 2006; Radomski et al., 2015) compared to the multitude of studies
investigating memory deficits or basic cognitive slowing (Chiaravalloti & DeLuca,
2008; Rogers & Panegyres, 2007; Roth et al., 2015). Traditionally, MS has been
thought of as a white matter disease, with focal demyelinating lesions in the white
matter being the pathological hallmark. However, this view has been challenged in
recent years. It is now known that grey matter areas including the cerebral cortex
can also be affected (M. Calabrese et al., 2012), a finding demonstrated first in
post-mortem analyses (Kidd et al., 1999). In addition to focal lesions, brains of
MS patients sometimes show considerable atrophy (Barkhof, 2002), which affects
not only white, but also grey matter structures. Atrophy can become manifest, for
example, as widespread cortical thickness reduction, with a predominant involve-
ment of temporal and frontal regions (M. Calabrese, Rinaldi, et al., 2010; Munger
et al., 2004; Sailer et al., 2003).
Modern MRI techniques and post-processing methods assessing atrophy parame-
ters contribute to the improvement in understanding the mechanisms responsible
for physical and cognitive impairment in MS (Filippi & Rocca, 2010). During
the last three decades, many studies have demonstrated an association between
white matter pathology and cognitive impairment (e.g Rao et al., 1989). However,
only modest correlations were found (e.g. Foong et al., 1997; Swirsky-Sacchetti
et al., 1992), so that a majority of variance in cognitive performance remained
unexplained. MRI markers of atrophy such as increased third ventricle width or
reduced total white and grey matter volumes are consistently found to correlate
more strongly with cognitive deficits (Amato et al., 2004; Benedict, Bruce, et al.,
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2006) than white matter lesion load. In the last decade, grey matter pathology, i.e.
cortical and deep grey matter atrophy and cortical lesion load, has been identified
as a significant substrate of cognitive impairment, by showing particularly strong
associations (e.g. Amato et al., 2004; M. Calabrese et al., 2009; Nielsen et al.,
2013; Zivadinov et al., 2001).
Despite the huge amount of correlation studies between different structural al-
terations and cognitive dysfunction in MS, focal-topological studies on specific
cognitive functions are rare. For example, deficits in sustained attention and work-
ing memory were related to lesions in bilateral frontal and parietal white matter
(Sperling et al., 2001), and deficits in verbal learning to lesions in the left frontal
lobe (Reuter & Fischl, 2011). With regard to atrophy, bilateral hippocampal at-
rophy has been related to impaired verbal learning (Sicotte et al., 2008).
The aim of the present study was to investigate executive dysfuncion in patients
with MS and to analyse its relationship with both global and regional MRI mark-
ers. Our methodological focus was on cortical thinning. Only few previous studies
have addressed the identification of cortical thinning in MS and its association to
global cognitive impairment (M. Calabrese, Rinaldi, et al., 2010; Morgen et al.,
2006; Tekok-Kilic et al., 2007). And to the best of our knowledge, only a single
study so far investigated the impact of regional cortical thinning on specific cog-
nitive disability, showing that focal thinning in the bilateral fusiform gyrus was
related to impaired processing of facial expressions (Mike et al., 2013). Here we ex-
tend this approach by examining whether similar foci can be found for MS-related
executive dysfunction.
5.2.3 Materials and methods
Participants
Forty-eight patients with a definite diagnosis of MS according to the McDonald
2010 criteria (Polman et al., 2011) and a relapsing-remitting course were recruited
at the Multiple Sclerosis Centre of the University Hospital of Zurich. Forty-seven
patients (98 %) were treated with an immunomodulatory drug - 32 with natal-
izumab, ten with beta-interferons, three with fingolimod, one with glatiramer ac-
etat, one with dimethylfumarate, and one patient had no disease-modifying ther-
apy. We applied the following exclusion criteria: a) relapse or steroid-treatment
during the last two months, b) current or past neurological disorder in addition
to multiple sclerosis, c) psychiatric disorder apart from multiple sclerosis-related
depressive mood state, d) a reading-relevant visual acuity deficit, and e) a writing-
and/or drawing-relevant upper limb sensorimotor impairment of the dominant
hand. Furthermore, 48 age-, gender-, handedness-, and education-matched healthy
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controls without previous or present history of neurological or psychiatric dysfunc-
tion were included. The study was approved by the regional Ethics Committee.
All participants provided written informed consent. Control participants received
financial compensation for their attendance.
Neuropsychological and neurological examination
Neuropsychological and neurological (only for the patient group) examinations
were performed within one month of the MRI scan described below by experi-
enced clinicians of the Multiple Sclerosis Centre. Five executive functions were
examined. First, verbal-phonematic fluency was assessed with the Regensburger
verbal fluency test (Aschenbrenner et al., 2000). Participants were required to
generate as many words as possible beginning with the letter “s” in two minutes.
Repetitions of word stems or deviations from test rules were regarded as errors; the
number of correct answers was further analysed. The HAMASCH-five-points-test
(Haid et al., 2002) was applied to assess figural fluency (Regard, Strauss, & Knapp,
1982). This test required participants to create as many unique designs as possi-
ble through connecting at least two dots of a five-dot pattern with straight lines
within three minutes. The total number of unique designs entered further analyses.
Furthermore, working memory was assessed by a two-back task(Zimmermann &
Fimm, 2007), where the total number of errors (number of misses plus number of
false positives) was further analysed. The Colour-Word-Interference subtest of the
Delis–Kaplan Executive Function System (Delis et al., 2001) was used to investi-
gate response inhibition and set shifting. In the interference condition, participants
had to name the colour of the ink in which the word was printed – which is at
conflict with the word meaning – while inhibiting the propensity to read the word.
In the switching condition, participants had to irregularly alternate between read-
ing the word and naming the ink, depending on the presence or absence of a box
surrounding the word. Again, ink colour and word meaning were always at con-
flict with one another. Furthermore, a third condition of the D-KEFS colour-word
interference test, i.e. the colour naming condition, served as a control parameter
for basic information processing speed. As this study focuses on executive func-
tions rather than on basic cognitive slowing, corrected time-to-completion indices
were calculated with this latter parameter, according to the procedure specified
by Delis and colleagues (2001). In other words, and concerning both interference
control and set shifting, two variables entered further analyses, i.e. the number of
correct answers and the corrected time-to-complete. Moreover, participants had to
complete a German version (Hautzinger & Bailer, 1992) of the CES-D Depression
questionnaire (Radloff, 1977) and the Wu¨rzburg Fatigue Inventory (WEIMuS)
(Flachenecker et al., 2008) to self-assess depressive symptoms as well as cognitive
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and physical fatigue during the last week. Similar to other studies (Sumowski
et al., 2014), cognitive reserve was examined with vocabulary knowledge. In our
study, the Multiple-Choice Word Test-B (Lehrl, 2005) was applied. Additionally,
Expanded Disability Status Scale (EDSS) scores (Kurtzke, 1983) were obtained in
all patients.
MR image acquisition protocol
All images were acquired with a neuro-optimised 1.5 Tesla MR scanner (Siemens
Magnetom AvantoTM) equipped with a SQ-engine gradient (45m/T/m @ 200
T/m/s) using a dedicated 32-channel head coil. The sequences acquired in each
subject included a T1-weighted Magnetisation Prepared Rapid Gradient Echo
(MPRAGE; voxel size = 1 x 1 x 1 mm, slice thickness = 1 mm, repetition time
= 2420 ms, echo time = 4.18 ms) and a T2-weighted Fluid Attenuated Inversion
Recovery sequence (FLAIR; voxel size = 0.9 x 0.9 x 2.0 mm, slice thickness = 2
mm, repetition time = 5000 ms, echo time = 342 ms).
Image analysis
T2-hyperintense lesion volume: FLAIR-hyperintense lesions were identified and
manually delineated with MRIcron (http://sph.sc.edu/comd/rorden/mricron), which
was also used to measure total lesion volume. An experienced rater (TP), su-
pervised by a neuroradiologist (BS), performed this lesion analysis. Statistical
Parametric Mapping (SPM8, http://www.fil.ion.ucl.ac.uk/spm/) was used to co-
register and normalize individual lesion maps to MNI (Montreal Neurological In-
stitute and Hospital) standard space. Normalized lesion maps were then mapped
on a template brain with MRIcron to create lesion overlap plots. Included in the
MRIcron package, the non-parametric mapping software (Rorden et al., 2007) was
used to analyze possible associations of behavioral performance with the spatial
distribution of lesions, i.e. voxel-based lesion symptom mapping (VLSM).
Central atrophy : Central brain atrophy was examined by measuring the width
of the third ventricle (TVW), applying the procedure specified by Benedict and
colleagues (Benedict, Bruce, et al., 2006). Accordingly, a line was drawn through
the long axis of the third ventricle parallel to the interhemispheric fissure on the
axial MPRAGE slice on which the third ventricle was best visible. Then a second
line, perpendicular to the first one, was drawn through the midpoint of the first
line and measured with the Jim software (Xinapse Systems Ltd., Northants (UK);
http://www. xinapse.com).
Cortical thickness analyses : Cortical thickness evaluation was performed with the
Freesurfer image analysis suite, which is documented and freely available online
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(http://surfer.nmr.mgh.harvard.edu). It is a set of automated processing proce-
dures, requiring 3D MPRAGE MRI images and comprising skull-stripping, reg-
istration, intensity normalization, Talairach transformation, tissue segmentation
and surface parcellation. Further information and technical details of the proce-
dures are described in prior publications (Fischl et al., 1999). To detect possible
misclassifications of white and grey matter, e.g. due to multiple sclerosis lesions,
all images were visually inspected after the white/grey matter segmentation. In
two patients, a semi-automated correction of topological defects was required by
manually adding control points.
Statistical analysis
Statistical analyses of the demographic and cognitive data were per- formed in
SPSS (IBM, Chicago, USA, Version, 21.0, http://spss.com). Un- less otherwise
stated, a p-level below 5% was considered statistically significant. Assumptions for
normality were tested for all continuous data with Kolmogorov–Smirnov tests, and
parametric (t-test, Pearson correlation) or non-parametric tests (Mann–Whitney-
U, Spearman rank correlation) were used when appropriate. Chi-Square tests
were conducted to test for differences in frequency distributions between the two
groups. Whole-brain vertex-wise statistical analyses of cortical thickness were per-
formed with the Query Design Estimate Contrast (Qdec) module implemented in
Freesurfer.
As a first step, we analysed significant group differences in demographic variables
(age, cognitive reserve, gender, handedness), fatigue, depressive symptoms, global
cortical thickness, third ventricle width, and executive functions. Further analy-
ses were restricted to those executive functions for which significant impairments
were observed. In order to analyse whole-brain vertex-wise differences in cortical
thickness between the two groups a general linear model (GLM) was used. Key
demographics (e.g. age, education) were not controlled for, as these did not sta-
tistically differ between groups. Group differences of the cortical thickness were
separately calculated for each hemisphere. A false discovery rate (FDR) of 0.05
was used to control for multiple comparisons.
As a next step, we analysed the association of impaired executive functions with
demographic and disease variables (age, disease duration, EDSS, education, fa-
tigue, depressive symptoms) within the patient group. Any variable significantly
associated with executive impairment were controlled for in subsequent analyses.
In a third step, the relative contribution of global MRI variables on executive
performance was examined by hierarchical regression analyses. Multicollinearity
between MRI variables was assessed using the variance inflation factor. In a final
step, the relationship between regional structural alterations and executive dys-
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function was examined. A general linear model at each vertex point of the cortical
surface model was used to investigate the correlation between areas of regional
cortical thickness with executive impairment. Statistical surface maps showing
significant correlations between cortical thinning and executive performance were
generated by thresholding the images of t-statistics at a 0.05 significance level,
corrected for FDR. For the VLSM we performed Brunner–Munzel tests (Brunner
& Munzel, 2000) at a threshold of 5% FDR to identify lesioned voxels associated
with executive deficits. Only voxels affected in at least two patients were con-
sidered for analysis. For all vertex- and voxel-wise analyses, only clusters with a
continuous extent of 10 mm2 were reported.
Figure 5.4: Spatial distribution of T2-hyperintense lesions: All normalised FLAIR-hyperintense
lesions of all patients are shown in the lesion maps, illustrating pronounced periventricular ac-
cumulation. Image orientation follows the radiological convention (right on left side). The color
bar indicates the number of overlapping lesions.
5.2.4 Results
Demographic, clinical and conventional MRI assessment
Age (p = 0.691), education (p = 0.398), gender (p = 0.999), and handedness (p =
0.506) did not significantly differ between controls and patients. An overview of
the main demographic, clinical and MRI features of patients and controls is given
in 5.4. Lesion probability maps are shown in Figure 5.4, displaying the expected
accumulation (Rossi et al., 2012) of of T2-hyperintense lesions in periventricular
areas.
Cognitive findings
Test and questionnaire results are displayed in Table 5.5. Cognitive reserve was
nearly identical in the two groups. Performances in the working memory, response
inhibition and set shifting tests did not significantly differ between controls and
patients (all p >0.05). However, differences were found in the number of items
generated during the verbal and figural fluency tasks (both p <0.001), with pa-
tients generating fewer items than controls in both tasks. Patients were signifi-
cantly slower in colour naming condition of the D-KEFS word-colour-interference
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Table 5.4: Demographic and disease characteristics of multiple sclerosis patients and
healthy controls.
RRMS patients Controls Z-/t-/X2 p-value
(n = 48) (n = 48) Score
Demographics
Age, years (mean, SD)a 38.8 (9.3) 38.0 (9.6) t = 0.398 0.691
Females/males (number) 37/11 37/11 X2 = 0.00 1
Years of education (median, range) 13 (11-22) 14 (11-20) Z = -0.846 0.398
Disease duration, years since diagnosis
(mean, SD)
6.5 (5.4) n/a n/a n/a
EDSS score (mean, SD) 2.69 (1.9) n/a n/a n/a
MRI metrics
T2-hyperintense volume, cm3 (mean,
SD)
8.82 (9.24) n/a n/a n/a
Cortical thickness global, mm (mean,
SD)a
2.33 (0.13) 2.42 (0.11) t = -3.435 <0.01**
Third ventricle width, mm (median,
range)
3.70 (1.2-12.7) 2.40 (1.2-7.4) Z = -4.785 <0.01**
Abbreviations: BPF = Brain parenchymal fraction (= parenchymal volume / parenchymal volume +
CSF volume), SD = standard deviation.
Unless otherwise noted statistical comparisons are based on Mann-Whitney U tests.
a Because of normal distribution in both samples statistical comparisons are based on t-tests.
* p< 0.05; ** p< 0.01
test, indicating slowed basic information processing (p <0.05). Moreover, patients
showed higher levels of cognitive (p = 0.003) and physical (p <0.001) fatigue, as
well as a higher level of depressive mood state (p = 0.025), relative to controls.
Verbal and figural fluency performances were not significantly associated with age,
disease duration, depressive symptoms, and cognitive or physical fatigue (all p
>0.05). However, our measure of cognitive reserve was related to verbal fluency (r
= 0.298; p = 0.02), while EDSS scores correlated with figural fluency performance
(r = 0.310; p = 0.03). Therefore, these two variables were controlled for in further
analyses.
MRI findings
Mean global cortical thickness was reduced in multiple sclerosis patients compared
to controls (Table 5.4; p <0.001). Whole-brain vertex-wise analysis revealed mul-
tiple brain areas of significant cortical thinning in both hemispheres in patients
compared with healthy controls (Figure 5.5). Cortical thinning was spread over
broad regions of both hemispheres. Anatomical locations of clusters of decreased
cortical thickness in the patients are summarised in the Supplemental Table 5.7
(see Section 5.2.6 for supplemental material).
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Table 5.5: Neuropsychological test and questionnaire results
RRMS patients Healthy Controls t-/Z-Score p-value
Executive functions
Verbal fluency, no. correct (median,
range)
18.5 (9-34) 25 (15-45) Z = -4.821 <0.01**
Figural fluency, no. correct (mean,
SD)a
32.42 (8.3) 43.23 (8.6) t = -6.266 <0.01**
Working memory, errors total (median,
range)
3.0 (0-16) 2.0 (0-11) Z = -1.611 0.107
Response inhibition, errors (median,
range)1
1.0 (0-7) 0.0 (0-5) Z = -1.805 0.071
Set shifting, errors (median, range)2 1.0 (0-9) 1.0 (0-5) Z = -0.756 0.45
Questionnaires
Cognitive fatigue (median, range) 5.5 (0-30) 2.0 (0-21) Z = -3.216 <0.01**
Physical fatigue (median, range) 6.0 (0-15) 1.5 (0-32) Z = -3.005 <0.01**
Total fatigue (median, range) 13.5 (0-55) 4.0 (0-36) Z = -3.332 <0.01**
Depressive symptoms (median, range) 9.0 (0-37) 6.5 (0-23) Z = -2.243 0.025*
Cognitive reserve
MWT-B (median, range) 30.5 (23-37) 31.0 (25-36) Z = -0.589 0.556
Abbreviations: MWT-B = Multiple-Choice Word Test-B; SD = Standard deviation
Unless otherwise noted statistical comparisons are based on Mann-Whitney U tests
a Because of normal distribution in both samples statistical comparisons are based on t-tests.
* p< 0.05; ** p< 0.01
1 Here, corrected time-to-complete means the difference of the scaled scores between the interference condition
and the basic color naming condition, as proposed by Delis et al. (2001)
2 Here, corrected time-to-complete means the difference of the scaled scores between the interference condition
and set shifting condition.
Figure 5.5: Differences in cortical thickness: Statistical maps representing significant cortical
thickness differences between patients and controls on lateral, medial, inferior and superior view
of inflated brains. A color scale indicates statistical significance and shows p-values. Red/yellow
areas represent clusters of significant cortical thinning in patients, relative to controls.
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Global analyses
The hierachical regression model accounted for 45.7% of the variance in verbal flu-
ency performance. No predictor indicated multicollinearity (all variance inflation
factors <4). After controlling for education in block one, lesion volume retained
in block two, with larger lesion volume predicting worse performance in verbal
fluency (R2 = 0.288, p = 0.003). In block three, TVW as an indicator of central
brain atrophy accounted for an additional 7% of variance in verbal fluency per-
formance, with more atrophy predicting worse verbal fluency performance (R2 =
0.364, p = 0.026). Finally, in block four global cortical thickness accounted for
additional 9 % of variance in verbal fluency, with a thinner cortex being associated
with worse verbal fluency performance (R2 = 0.457, p = 0.010). In other words,
cortical thickness independently predicted verbal fluency, even when controlling
for lesion volume and central brain atrophy estimates. Regarding figural fluency,
the full regression model accounted for 30.2% of variance in figural fluency perfor-
mance. After controlling for EDSS in step one, there was a negative effect of lesion
volume on figural fluency (R2 = 0.285, p = 0.009) in block two, but no effect of
brain atrophy (TVW) in block 3 (p = 0.335) or cortical thinning in block four (p
= 0.729). Within the control group, neither global cortical thickness nor the TVW
significantly correlated with verbal or figural fluency performance (all p >0.05).
Regional analyses
Clusters of significant correlations between regional cortical thickness and verbal or
figural fluency performance within the patient group are shown in Figure 5.6 and
Table 5.6. Poorer performance in the verbal fluency task correlated with a thinner
cortex within the left anterior cingulate, superior frontal, lateral orbitofrontal,
fusiform and superior parietal region. These clusters survived FDR-correction.
Performance in the figural fluency task was associated with cortical thickness in
the right anterior cingulate and insula. No significant correlations were observed in
the control group. Concerning the relation of T2-hyperintense lesion location with
fluency, VLSM revealed no clusters of lesioned voxels associated with performance
in the two fluency tasks.
5.2.5 Discussion
The results of the present study indicate that executive dysfunction in patients
with multiple sclerosis can specifically affect verbal and figural fluency. For both
deficits, side- and site-specific cortical correlates in the anterior cingulate region
were found by means of cortical thickness analysis. Although several clusters of
cortical thinning were associated with verbal and figural fluency, only one of them
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Figure 5.6: Association of cortical thickness and fluency performance: Correlation of fluency
performance and cortical thickness within patients. On the left side, statistical maps show
clusters of significant correlation between verbal (A) and figural (B) fluency performance and
cortical thickness in the patient groups. On the right side, scatterplots illustrate the correlation
between cortical thickness in the anterior cingulate cortex cluster and verbal (A), respectively
fluency (B) performance.
Table 5.6: Regions of cortical thinning significantly associated with verbal and
figural fluency in the patient group
Cluster Talairach Coordinates Surface extension -log(p) Structures
Number x, y, z (mm2)
Left hemisphere, medial surface
Verbal fluency
1 -35.5, 17.1, -19.6 109.6 5.412 Fusiform
2 -10.5, 52.3, 9.6 50.75 4.999 Superior frontal
3 -14.2, 23.8, -16.4 85.84 4.956 Lateral orbitofrontal
4 -34.0,-48.4, -10.2 58.35 4.739 Fusiform
5 -8.3, 21.8, 27.9 44.60 5.676 Caudal anterior cingulate
Right hemisphere, medial and lateral surfaces
Figural fluency
1 13.1, 10.6, 37.3 46.01 5.386 Anterior cingulate
2 34.1, 3.3, 7.6 17.61 4.664 Insula
All p-values corrected for multiple comparison using FDR = 0.05. Small significant clusters
are not shown (Cluster size <10mm2). Anatomical terms are used according to the Desikan-
Killiany template.
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was congruent across the two hemispheres, i.e. the one in the anterior cingulate
cortex. The main finding of the present study is the lateralized characteristic
of the correlational analyses: Thinning in the left anterior cingulate cortex pre-
dicted verbal – but not figural – fluency, while the opposite pattern was found
for thinning in the right anterior cingulate cortex. This lateralisation corresponds
well with lesion studies in patients with focal brain damage linking verbal fluency
with the left prefrontal cortex and figural fluency with the right prefrontal cortex
(Robinson, Shallice, Bozzali, & Cipolotti, 2012; Schwartz & Baldo, 2001). These
studies were based on patients with relatively large focal lesions, for example due
to stroke or brain tumours. On the basis of focal grey matter atrophy, our study
demonstrates the same lateralised clinico-anatomical correlation pattern in MS,
which is traditionally seen as a white matter disease with widespread pathology.
Previous studies showed that tests of verbal fluency are amongst the most sensitive
neuropsychological instruments to assess cognitive impairment in multiple sclero-
sis, relative to other measures of executive functioning (Henry & Beatty, 2006).
Fluency tasks in general have a long tradition in the examination of one of the
most important executive function, i.e. the voluntary generation of new series of
responses. Sustained activation for the duration of the task is required in order to
generate non-overlearned responses for all types of fluency tasks (Robinson et al.,
2012). Performance deficits on fluency tasks are due to a failure of “energisation”
(Stuss & Alexander, 2007), that is, the process of initiating and sustaining any
response, which is required for the generation of new responses.
In this framework, the fluency deficits found in the present study could be re-
labelled “cognitive hypoenergisation”. It might be tempting to view this latter
concept as identical to that of cognitive fatigue. However, in line with previous
studies showing that self-reported fatigue is not associated with cognitive deficits
in multiple sclerosis (Morrow et al., 2009), we did not find a significant correla-
tion between fluency performance and self-reported cognitive fatigue in our patient
sample.
Patients with large medial frontal lobe lesions that involve the cingulate cortex
often show deficits in spontaneous initiation of speech and movement and/or an in-
ability to suppress externally triggered subroutines (Paus, 2001). Akinetic mutism,
which is caused by bilateral medial frontal lesions, represents an extreme exam-
ple of this clinico-anatomical association (Barris & Schuman, 1953). Robinson
and colleagues (2012) conclude that energization processes – necessary for fluency
tasks – are bilaterally represented in the medial frontal region. To the best of
our knowledge, we here show for the first time that the relation between anterior
cingulate pathology and hypoenergetic cognitive functioning can also be found in
patients with multiple sclerosis.
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With regard to the clinical assessment of executive functions in multiple sclerosis,
we propose that the inclusion of fluency tasks is particularly relevant. These brief
tests are sensitive to executive impairment and – as suggested by our findings –
cortical involvement, providing clinicians’ efficient tools in situations when exam-
ination time is limited.
Comparable to previous studies, we could only find modest association between
T2-hyperintense lesion burden and cognitive test performance. Roosendaal and
colleagues (2009) suggest that one main reason of this is that pathology outside
the focal white matter lesions, in the so-called normal appearing white matter
(NAWM), remains largely undetected by conventional MRI. By now, there is ev-
idence that advanced MRI sequences, such as diffusion tensor imaging (DTI) ex-
hibit more robust relationship with cognitive variables (e.g. Roosendaal et al.,
2009; Van Hecke et al., 2010), as it provides in-vivo information about the ori-
entation and integrity of WM fibre bundles. Thus, NAWM changes should be
investigated as an additional mechanism related to cognitive dysfunction beside
T2-hyperintense lesion volume, central and cortical atrophy. Furthermore, DTI –
potentially in combination with fMRI – would allow analyses of neuroconnectivity
and neuronal net- works. As cognitive functions and thus also fluency perfor-
mances are likely based on a network of brain regions – rather than on a single
region – additional knowledge could be gained with such analyses. Based on previ-
ous and our findings, we propose that the AC is an important node of the fluency
network.
The present study is not without limitations: First, only MS patients suffering
from the relapsing-remitting subtype were included, so that the generalisation of
the findings to other forms of multiple sclerosis such as the primary progressive
variant is debatable. Furthermore, the cross-sectional design of the study does not
allow causal interpretation of the observed association between structural MRI
changes and cognitive impairment.
5.2 Study 2 53
5.2.6 Supplemental material
Table 5.7: Clusters of cortical areas (left and right hemisphere) showing significant cortical
thinning in relapsing-remitting MS patients compared to healthy controls
Cluster Talairach Coordinates Surface extension -log(p) Structures
Number x, y, z (mm2)
Left hemisphere
1 -18.3 -67.3 0.7 965.56 6.1365 lingual
2 -110.3 346.46 5.709 fusiform
3 -7.5 38.6 30.9 2019.97 -5.4904 superior frontal
4 -36.5 -36.5 16.5 130.09 5.0554 supra marginal
5 -34.2 8.6 25.2 134.52 4.5666 caudal middle frontal
6 -22.4 -4.3 46.1 125.03 4.5499 caudal middle frontal
7 -49.6 10.3 -19.1 384.85 4.3821 superior temporal
8 -40.8 -53.5 12.7 94.95 4.2618 inferior parietal
9 -33.5 -20.6 18.3 153.56 4.2511 insula
10 -60.9 125.24 4.2286 entorhinal
11 -58.0 3.7 10.1 129.66 4.1442 precentral
12 -104.5 261.83 4.0364 middle temporal
13 -42.2 -63.3 36.3 174.07 3.7251 inferior parietal
14 -28.8 -78.0 14.1 94.9 3.6089 inferior parietal
15 -26.6 24.1 -8.3 57.94 3.5256 lateral orbitofrontal
16 -65 91.34 3.5171 superior temporal
17 -24.1 -60.9 41.2 78.04 3.3917 superior parietal
18 -118.5 121.52 3.2174 lateral occipital
19 -33.6 23.6 -19.3 95.67 3.2063 lateral orbitofrontal
20 -13.6 -16.6 44.2 35.23 3.1067 paracentral
21 -117.1 200.44 3.0842 lateral occipital
22 -21.5 20.5 41.8 78.75 3.073 superior frontal
23 -5.2 -83.9 26.1 124.36 2.9508 cuneus
24 -84.1 81.36 2.9237 inferior temporal
25 -5.5 -60.2 14.4 35.37 2.8229 precuneus
26 -43.8 -68.3 7.9 16.07 2.6849 inferior parietal
Right hemisphere
1 24.9 -6.5 -31. 101.61 6.6866 entorhinal
2 41.3 -57.9 17.6 897.57 5.847 inferior parietal
3 9.5 8.4 65.1 366.74 5.7239 superior frontal
4 24.4 -3.8 45.5 267.35 5.5027 precentral
5 12.9 -56.0 18.9 203.81 5.2272 precuneus
6 33.6 2.6 13.3 182.28 4.9933 insula
7 34.6 -21.7 20.7 303.28 4.6877 insula
8 10.6 27.8 55.3 92.63 4.2329 superior frontal
9 35.4 -5.7 -35.9 133.16 4.1083 fusiform
10 32.5 11.3 30.2 179.98 4.0422 caudal middle frontal
11 28.4 -88.5 1.2 261.28 3.905 lateral occipital
12 19.5 -45.8 -2.0 314.41 3.7091 isthmus cingulate
13 42.1 -51.5 -11.6 119.44 3.6543 fusiform
14 49.9 -10.6 -13.9 114.26 3.6519 superior temporal
15 32.8 -53.9 -15.8 55.73 3.6105 fusiform
16 11.1 -91.7 13.7 177.02 3.5916 cuneus
17 30.1 17.5 44.8 95.06 3.5655 caudal middle frontal
18 20.9 -62.0 41.1 83.6 3.5186 superior parietal
19 10.8 55.8 -5.4 82.28 3.4249 medial orbitofrontal
20 33.5 14.9 -36.3 123.59 3.3771 temporal pole
21 60.6 -41.3 15.5 60.55 3.3744 bankssts
22 15.3 -93.9 -6.0 74.21 3.2249 pericalcarine
23 11.5 -4.6 46.9 45.83 3.2019 superior frontal
24 54.1 -38.6 45.2 35.43 3.1808 supramarginal
25 60.5 -5.0 13.4 120.15 3.1535 postcentral
26 52.2 -4.8 9.9 35.23 2.9518 precentral
27 37.9 42.6 10.3 60.32 2.9027 rostral middle frontal
28 47.9 -34.3 12.4 45.6 2.8328 superior temporal
29 59.0 -56.2 4.8 37.85 2.7796 middle temporal
Anatomical terms are used according to the Desikan-Kiliany template.
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5.3.1 Abstract
Human subjects typically deviate systematically from randomness when attempt-
ing to produce a sequence of random numbers. Despite an increasing number
of behavioral and functional neuroimaging studies on random number generation
(RNG), its neuroanatomical underpinnings have never been investigated. We set
out to fill this gap in 44 patients with multiple sclerosis (MS), a disease whose
impact on RNG has never been studied. The RNG task required the paced (1
Hz) generation of the numbers from 1 to 6 in a sequence as random as possi-
ble. The same task was administered in 39 matched healthy controls. To assess
neuroanatomical correlates such as cortical thickness, lesion load and third ven-
tricle width, all subjects underwent high-resolution structural MRI. Compared to
controls, MS patients exhibited an enhanced tendency to arrange consecutive num-
bers in an ascending order (“forward counting”). Furthermore, patients showed a
higher susceptibility to rule breaks (producing out-of-category digits like 7) and
to skip beats of the metronome. Clinico-anatomical correlation analyses revealed
two main findings: First, increased counting in MS patients was associated with
higher cortical lesion load. Second, increased number of skipped beats was related
to widespread cortical thinning. In conclusion, our test results illustrate a loss of
behavioral complexity in the course of multiple sclerosis, while the imaging results
suggest an association between this loss and cortical pathology.
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5.3.2 Introduction
As smart human brains are in spotting patterns and following rules, as miserably
they fail in attempting to be unpredictable. A case in point is our inability to
generate random sequences of responses. Instructions of a random number gener-
ation (RNG) task require subjects to arrange numbers in a sequence “as random as
possible”, implicitly asking to avoid any algorithm and to disobey any rule. Under
a huge range of conditions (Brugger, 1997) healthy volunteers were found unable
to follow these instructions, and so were patients with various neuropsychiatric
diseases (Brown, Soliveri, & Jahanshahi, 1998; Brugger et al., 1996; Ho, Sahakian,
Robbins, & Barker, 2004; Salame´ & Danion, 2007; Spatt & Goldenberg, 1993).
A limited capacity of working memory and executive functions have been implied
in the failure to produce unpredictable, or random sequences of response alterna-
tives (Baddeley, 1966; Baddeley et al., 1998; Joppich et al., 2004; Maes, Eling,
Reelick, & Kessels, 2011; Miyake et al., 2000). Neuroimaging studies have largely
supported the assumed implication of the (pre)frontal lobes for RNG (Artiges et
al., 2000; Itagaki, Niwa, Itoh, & Momose, 1995) and non-invasive intervention
methods have suggested their causal involvement (Jahanshahi et al., 1998; Knoch,
Brugger, & Regard, 2005).
Facing the large and rapidly growing number of behavioral and functional neu-
roimaging studies on RNG, one is left wondering why the neuroanatomical corre-
lates of RNG have never been examined. The present study was aimed at filling
this gap in patients with multiple sclerosis (MS), a disease whose impact on RNG
has, to the best of our knowledge, never been studied. MS, the most common au-
toimmune disorder affecting the central nervous system, is historically considered
a white matter (WM) disease, with focal demyelinating lesions in the WM being
the pathological hallmark. However, several recent neuropathological studies dis-
closed a relevant involvement of gray matter areas including the cerebral cortex
(M. Calabrese et al., 2012; Geisseler et al., 2016). Brain integrity, captured by
various imaging techniques, has been shown to correlate with cognitive impair-
ment (for review see (for review see Rocca et al., 2015), which is recognized as
an important feature of MS, prevalent in 43-70% of MS patients (Chiaravalloti &
DeLuca, 2008). Although processing speed (e.g. DeLuca et al., 2004; Roth et al.,
2015) and episodic memory (e.g. Rogers & Panegyres, 2007) seem to be the most
prominent cognitive feature of MS, these patients often exhibit significant deficits
in executive functions (Geisseler et al., 2016; Henry & Beatty, 2006). Against this
background, it appears tempting to assume that MS patients exhibit impaired
performance in generating random sequences of numbers.
The aim of the present study is two-fold. On the one hand, we planned to examine
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the impact of MS on randomization performance; on the other hand, we wanted to
explore, for the first time, the neuroanatomical correlates of RNG. Specifically, we
predicted an impaired randomization performance by the patients with MS rela-
tive to a carefully matched healthy control group. As a first step in uncovering the
neuroanatomical correlates of RNG, we planned to analyze associations between
brain structure and RNG performance in healthy participants and, in the patient
group, between cortical and subcortical damage and RNG performance.
5.3.3 Methods
Participants
Forty-four patients with a definite diagnosis of relapsing-remitting multiple sclero-
sis (RRMS) according to the 2010 McDonald criteria (Polman et al., 2011) and 39
age-, gender-, handedness- and education-matched healthy controls participated
in this study. Inclusion criteria for the patient group were no relapse or steroid-
treatment during the last two months, no current or past neurological disorder in
addition to multiple sclerosis, and no psychiatric disorders apart from MS-related
depressive mood state. The local ethics committee approved the study, and all
subjects gave written informed consent before participation. Control participants
received financial compensation.
RNG task, performance measures and hypotheses
The Mental Dice Task (MDT) was administered in its standardized form (Brugger
et al., 1996). Subjects were instructed to imagine repeatedly throwing a die and to
orally report the number that would show up, i.e., they had to generate numbers
from 1 to 6 in a random fashion. Subjects were instructed to synchronize their
response with a pacing auditory stimulus, which was a beeping sound presented
at 1 Hz. A total of 66 valid responses were recorded.
While there are many different measures of (non)randomness, we focused on three
variables, which were calculated by means of a freely available computer pro-
gram (http://www.lancs.uk/staff/towse/rgcpage.html). First, we determined the
distribution of first-order differences (FODs), reflecting the arithmetic difference
between each response and the preceding one. Thus, FODs may vary between
-5 (6 followed by 1) and +5 (1 followed by 6). A value of 0 is scored when any
of the six numbers are repeated. The frequency of zero values can be used to
measure repetition avoidance, with fewer zeroes indicating more alternations. We
predicted a comparable degrees of repetition avoidance for both groups, as rep-
etition (alternation) behavior may be under hippocampal, rather than prefrontal
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control (Lalonde, 2002). An FOD value of +1 reflects a counting strategy, which we
predicted to be pronounced in patients with MS, under the assumption of an im-
paired executive control of automatized responding. Figure 1 displays all possible
pair combinations and the expected frequencies of the resulting 11 different FODs.
Second, the frequency of shifts between ascending and descending sequences is
captured by the turning point index (TPI). TPI is reported as a percentage score,
meaning that values greater than 100 indicate too many turning points - relative
to a theoretical distribution of random responses - whereas values less than 100
indicate fewer turning points than expected. We predicted that patients showed
a lower TPI than patients, again because an impaired suppression of automatized
counting upwards and downwards would lead to longer ascending and descending
sequences. Finally, as a global measure of randomness, Evans’ random number
generation index (Evans (1978); RNG index) was calculated, ranging from 0 to
1, with higher indices representing less randomness, which was predicted for the
patient group. Further information and mathematical details of these calculations
are described elsewhere (Towse & Neil, 1998).
Additionally, and besides these measures of sequential non-randomness, two non-
sequential variables of the MDT were considered, i.e., the number of rule breaks
(i.e., producing out-of-category digits such as 7) and the total number of skipped
beats of the metronome.
MRI data acquisition, post-processing and hypotheses
The MRI scan was performed within one month of the neuropsychological ex-
amination. All images were acquired using a 1.5-T scanner (Siemens Magnetom
AvantoTM) equipped with a SQ-engine gradient (45m/T/m @ 200 T/m/s) using
a dedicated 32-channel head coil. No hardware upgrades of the scanner occurred
during the study period. The following sequences were obtained from all subjects:
(1) Double Inversion Recovery sequence (DIR) (voxel size =1.5 x 1.5 x 1.5 mm,
slice thickness = 1.5 mm, repetition time = 7500ms, echo time = 308ms); (2) T1-
weighted MPRAGE (voxel size = 1 x 1 x 1 mm, slice thickness = 1 mm, repetition
time = 2420 ms, echo time = 4.18 ms) and (3) a T2-weighted FLAIR (voxel size =
0.9 x 0.9 x 2.0 mm, slice thickness = 2 mm, repetition time = 5000 ms, echo time =
342 ms). Cortical lesions were defined according to the consensus recommendations
of Geurts and colleagues (2011). Consequently, cortical lesions are those lesions
appearing hyperintense on DIR images compared to surrounding normal-appearing
grey matter, entirely or partly located in the cortical grey matter and occupying
at least three voxels. DIR-hyperintense lesions were identified and manually delin-
eated with MRIcron (http://sph.sc.edu/comd/rorden/mricron), which was further
used to measure total lesion volume. The same procedure was applied to FLAIR
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Table 5.8: Demographic characteristics and measures of performance
on the MDT of MS patients and healthy controls
MS patients Controls p-value
Number 44 39 -
Gender [m/f] 10/34 6/33 0.397
Age [years], mean (SD) 39.02 (9.4) 38.53 0.813
Education [years], mean (SD) 14.6 (3.1) 14.3(2.4) 0.69
EDSS, mean 2.6 - -
Disease duration [months], mean 79.5 - -
RNG, mean 0.47 0.43 0.151
Counting [FOD 1], mean 15.91 11.54 0.004**
Repetition avoidance [FOD 0], mean 3.11 3.51 0.699
TPI, mean 77.02 89.84 < 0.001***
Skipped beats, mean 6.52 0.18 < 0.001***
Rule breaks, mean 0.37 0.1 0.014*
Abbreviations: EDSS = Expended disability status scale, RNG = Random
number generation, FOD = First order difference, TPI = Turning point index.
images to identify and segment T2-hyperintense lesions. An experienced rater as-
sessed all images, supervised by a neuroradiologist. Central brain atrophy was
examined by measuring the width of the third ventricle, implemented according to
the procedure defined by Benedict and colleagues (2006). Similar to many other
studies on cognition in MS (e.g. Benedict, Bruce, et al., 2006), we expect a wider
third ventricle to be associated with poorer behavioral performance. Cortical thick-
ness evaluation was performed by means of Freesurfer image analysis suite, which is
documented and freely available online (http://surfer.nmr.mgh.harvard.edu). Fur-
ther information and technical details of these procedures are described in prior
publications (Dale et al., 1999; Fischl et al., 1999). To detect possible misclas-
sifications of white and grey matter due to multiple sclerosis lesions, all images
were visually inspected after the segmentation of grey and white matter. In one
patient, a semi-automated correction of topological defects was required by man-
ually adding control points. Global cortical thickness as well as cortical thickness
estimates for the regions resulting from automated parcellations (Desikan et al.,
2006) were extracted from the Freesurfer software for further analyses. In line with
the hypothesis that RNG performance rely on frontal functions, we mainly focused
on frontal regions of interest (ROI), whereas temporal and parieto-occipital ROI
were used as control regions.
Statistical analyses
Statistical analyses of the demographical and cognitive data, including group
comparisons, were performed with SPSS (IBM, Chicago, USA, Version, 21.0,
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http://spss.com). Unless otherwise stated, a p-level below 5% was considered sta-
tistically significant. Assumptions for normality were tested for all continuous data
with Kolmogorov-Smirnov tests. In case of normally distributed variables, group
comparisons and correlational analyses were based on parametric tests (indepen-
dent t-tests, Pearson correlation). When variables were not normally distributed,
non-parametric tests (Mann-Whitney U test, Spearman correlation) were applied.
Concerning all group comparisons, correlational analyses and ROI analyses, Bon-
ferroni correction was used to prevent alpha error inflation.
5.3.4 Results
RNG findings
Demographic characteristics and MDT test results are reported in Table 5.8. The
distribution of FODs is shown in Figure 5.7, and an overview of the RNG param-
eters is given in Table 5.8. Patients displayed significantly (T(67.9) = 3.010; p =
0.004) more forward counting steps (Mean = 15.91; SD = 8.335) than healthy con-
trols (Mean = 11.54; SD = 4.541). Furthermore, the latter showed more backward
counting steps of two than the patients (FOD = -2; T(81) = -2.490; p = 0.015).
No differences between groups were observed in the number of repetitions (FOD =
0). Patients (Mean = 77.02; SD = 18.17) had a smaller TPI than controls (Mean
= 89.8, SD = 13.33), i.e. they showed less changes from ascending to descending
sequences and vice versa (T(81) = -3.624, p < 0.001). RNG indices did not differ
significantly between groups (Z = -1.437; p = 0.151). Regarding non-sequential
measures, MS patients showed a higher susceptibility to rule breaks (Z = -2.431;
p = 0.014) as well as to skip beats of the metronome (Z = -4.983, p < 0.001) than
the control group.
Correlational analyses within the patient group yielded no relationship between
RNG parameters and age, education, disease severity (EDSS), fatigue or depressive
mood (all p > 0.050).
MRI findings
Relative to controls, patients showed significant cortical thinning and widening of
the third ventricle (both p < 0.010). Results of the univariate correlation analyses
between the global atrophy and the RNG parameters as well as between the lesion
and the RNG parameters within the patient group are summarized in Table 5.9.
Within the patient group, mean global cortical thickness showed a significant neg-
ative correlation with skipped beats in the MDT (rs = -0.411, p = 0.006), i.e. a
thinner cortex was associated with more skipped beats. In contrast, global corti-
cal thickness was not associated with TPI, counting tendency, or the number of
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Figure 5.7: Distribution of first-order differences (FODs). Avoidance of repetitions is demon-
strated at point 0 on the x-axis, forward counting at point 1, backward counting at point -1.
.
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Table 5.9: Spearman correlations between measures of the Mental Dice Task (MDT) and neu-
roimaging parameters in patients with relapsing-remitting multiple sclerosis (n=44)
Sequential measures Non-sequential measures
TPI Counting tendency Skipped beats Rule breaks
rs(p-value) rs(p-value) rs(p-value) rs(p-value)
Atrophy parameters
Cortical thickness 0.078 (0.614 ) -0.161 (0.296 ) -0.411(0.006**a) 0.112 (0.467 )
Third ventricle width -0.110 (0.477 ) 0.332 (0.028 ) 0.237 (0.122 ) 0.174 (0.259 )
Lesion parameters
T2-hyperintense lesion load -0.190 (0.217 ) 0.270 (0.076 ) 0.345 (0.022 ) 0.015 (0.922 )
Cortical lesion load -0.053 (0.731 ) 0.402 (0.007**a) 0.306 (0.043 ) -0.094 (0.545 )
Abbreviations: TPI = Turning point index
a The correlation remained significant when using a stringent Bonferroni correction (alpha = 0.05/8 =
0.00625)
* p < 0.05; ** p < 0.01
rule breaks (all p > 0.050). The width of the third ventricle did not correlated
with any of the RNG parameters. Regarding lesion parameters, DIR-hyperintense
lesion volume correlated with the counting tendency (r = 0.402; p < 0.007; Figure
5.8). However, both DIR-hyperintense cortex-involving (r = 0.306; p = 0.045) as
well as FLAIR-hyperintense lesion volumes (r = 0.345; p = 0.022) were uncorre-
lated with the TPI and the non-sequential parameters. None of the global MRI
variables correlated with TPI or the number of rule breaks.
On a regional level, ROI analyses revealed no significant correlation between count-
ing tendency and the cortical thickness in frontal regions of interest when applying
strict Bonferroni correction. Supplementary Table 5.10 (supplemental material in
Section 5.3.6) shows r- and uncorrected p-values (which ranged between r = -
0.359, p < 0.009 and r = 0.018, p < 0.454). Similarly, no significant correlation
was observed between the temporal and parietal control ROIs with any sequential
parameters. Regarding non-sequential parameters, the ROI-based correlational
analyses did also not survive Bonferroni correction; Supplementary Table 5.11 (in
Section 5.3.6) displays uncorrected p-values.
Within the control group, the only significant correlation between global corti-
cal thickness and the RNG parameters was that with skipped beats (rs = -0.342,
p < 0.033). No significant correlations were observed between the width of the
third ventricle or global cortical thickness and any of the RNG parameters, and
the regional ROI analyses were also uncorrelated with both sequential and non-
sequential measures of the MDT (see Supplementary Table 5.12 for uncorrected
correlation values).
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Figure 5.8: Correlation between cortical lesion volume (cm3) and the counting tendency (fre-
quency of FOD 1)
5.3.5 Discussion
The current study examined the behavioral performance and neuroanatomical un-
derpinnings of RNG in a cohort of MS patients, compared with a group of matched
healthy controls. As predicted, random number sequences generated by MS pa-
tients were more stereotyped than those of healthy controls. More precisely, MS
patients showed more ascending counting behavior than control subjects. This
corresponds well with previous reports of a deterioration of randomization perfor-
mance in the presence of a neurological disorder (Brown et al., 1998; Brugger et
al., 1996; Ho et al., 2004) and with the observation of executive dysfunction in MS
(Drew et al., 2008). Patients did not differ from controls in the global measure of
randomness (RNG index; 0.47 and 0.43, respectively), perhaps due to a “floor ef-
fect”; both groups scored far from the value obtained in 100 simulations of 66 dice
throws, i.e. 0.36 (see Brugger et al. (1996)). Relative to healthy controls, patients
also exhibited problems in non-sequential parameters. They showed pronounce
difficulties in keeping pace (1Hz) and in avoiding invalid numbers (e.g. 7). The
former problem is consistent with reports that the primary cognitive deficit in MS
patients may be generalized slowing of information processing speed (DeLuca et
al., 2004). Thus, compared with healthy controls, MS patients completed substan-
tially fewer items on rapid serial processing tests such as for example the Paced
Auditory Serial Addition Test (PASAT; Parmenter, Shucard, and Shucard (2007)).
Consequently, the non-sequential variable of skipped beats in the RNG may be a
useful parameter for a brief and valid assessment of information processing speed.
Cognitive impairment in MS patients has been related to a number of structural
abnormalities in the past. Demyelinated T2 lesions in the white matter – the
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pathological hallmark of MS – are only modestly correlated with cognitive impair-
ment (Lazeron et al., 2005; Rao et al., 1989). Higher correlations are observed
between cognitive performance and third ventricle width, which is considered the
best single MRI predictor for MS-related cognitive impairment
(Benedict, Bruce, et al., 2006; Benedict et al., 2004). More recent research high-
lights cortical pathology as one of the major substrates of cognitive decline in MS
(for review see Messina & Patti, 2014). Our clinico-anatomical correlation analyses
revealed two main findings that survived Bonferroni correction: First, increased
counting in MS patients was associated with higher cortical lesion load. Second,
increased number of skipped beats were related to widespread cortical thinning.
No structural correlates could be found for the number of rule breaks and the
TPI-measure of sequential randomness. FLAIR-hyperintense lesion load did not
correlate significantly with any of the behavioral parameters.
The association between a widespread thinner cortex and an increased number of
skipped beats is among the most robust findings of the present study. Previous
studies showed that the volume or thickness of the neocortex is correlated with
mental processing efficiency in MS (Amato et al., 2007; Benedict, Bruce, et al.,
2006). We propose that skipped beats tightly reflect speed and attention, both in
MS patients and healthy controls.
To the best of our knowledge, this is the first study evaluating the RNG perfor-
mance by means of structural MRI. Our results suggest an association between
cortical pathology and RNG performance. On a behavioral level, it can be con-
cluded that even when compensating for difficulties by slowing the rate at which
they produced numbers, MS patients commit rule breaks and cannot sufficiently
suppress a counting algorithm. RNG may be a useful tool in the clinical mon-
itoring of MS. As the task is highly resistant to practice effects (Brugger, 1997;
Jahanshahi, Saleem, Ho, Dirnberger, & Fuller, 2006), it may prove particularly
suitable for monitoring cognitive capacity over time.
Future studies could employ lesion-symptom mapping analyses in patients with fo-
cal lesions to establish connections between brain circuitry and selected measures
of sequential non-randomness. Structural connectivity analyses will also be needed
to better understand neurostructural underpinnings of randomization performance
in health and disease.
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5.3.6 Supplemental material
Table 5.10: Spearman correlation of sequential parameters with the cortical thickness of
ROIs
Left hemisphere Right hemisphere
TPI FOD1 TPI FOD1
rs p-value rs p-value rs p-value rs p-value
Frontal
caudal middle frontal 0.149 0.168 -0.051 0.371 -0.038 0.402 0.103 0.253
lateral orbito frontal 0.067 0.332 -0.181 0.12 -0.044 0.389 -0.016 0.459
medial orbito frontal -0.105 0.249 -0.061 0.348 -0.169 0.137 -0.03 0.422
pars opercularis -0.012 0.468 0.100 0.259 -0.08 0.304 0.047 0.380
pars orbitalis 0.115 0.229 -,358 0.009 0.052 0.369 -0.147 0.171
pars triangularis 0.184 0.116 -,294 0.027 0.192 0.106 -,321 0.017
precentral 0.11 0.239 -0.024 0.439 0.163 0.146 -0.097 0.266
rostralmiddlefrontal 0.11 0.238 -0.177 0.125 0.121 0.217 -0.203 0.093
superior frontal 0.16 0.15 -0.101 0.257 0.149 0.168 -0.064 0.339
frontal pole -0.049 0.375 0.018 0.454 0.122 0.215 -0.17 0.135
Temporal
superior temporal 0.225 0.071 -0.18 0.121 0.078 0.307 -0.114 0.23
middle temporal 0.127 0.205 -0.049 0.377 0.051 0.37 -0.071 0.324
inferior temporal 0.167 0.139 -0.069 0.329 0.065 0.338 0.022 0.443
fusiform 0.042 0.393 -0.02 0.448 0.062 0.345 -0.011 0.472
transverse temporal -0.13 0.2 0.15 0.166 0.062 0.346 0.047 0.38
entorhinal 0.062 0.345 -0.047 0.382 -0.067 0.333 0.043 0.392
temporale pole 0.096 0.269 -0.093 0.274 0.083 0.295 -0.166 0.141
parahippocampal 0.207 0.089 -0.131 0.198 0.087 0.288 -0.044 0.39
Parieto-occipital
superior parietal 0.017 0.456 -0.006 0.484 0.125 0.21 -0.014 0.464
inferior parietal 0.116 0.227 -0.059 0.351 0.028 0.429 0.051 0.372
supramarginal 0.064 0.341 -0.095 0.27 0.004 0.49 -0.043 0.391
postcentral 0.122 0.216 -0.079 0.306 -0.116 0.227 0.115 0.228
precuneus 0.166 0.141 -0.129 0.203 0.052 0.368 -0.077 0.309
lateral occipital 0.027 0.43 0.04 0.397 0.094 0.272 -0.092 0.277
lingual -0.085 0.292 0.102 0.256 -0.061 0.348 0.031 0.422
cuenus -0.099 0.262 0.074 0.317 0.113 0.232 -0.138 0.186
pericalcarine -0.182 0.119 0.201 0.096 0.19 0.109 -0.153 0.16
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Table 5.11: Spearman correlation of nonsequential parameters with the cortical thickness of
ROIs
Left hemisphere Right hemisphere
Skipped beats Rule breaks Skipped beats Rule breaks
r p-value r p-value r p-value r p-value
Frontal
caudal middle frontal -,370 0.007 -0.022 0.443 -0.251 0.05 0.207 0.088
lateral orbito frontal -,294 0.027 -,314 0.019 -0.111 0.236 -0.14 0.183
medial orbito frontal -0.245 0.055 -0.131 0.198 -,288 0.029 0.106 0.246
pars opercularis -0.191 0.107 0.121 0.217 -0.244 0.055 -0.001 0.496
pars orbitalis -0.125 0.21 -0.089 0.284 -0.119 0.221 0.135 0.192
pars triangularis -,312 0.02 -0.104 0.25 -0.23 0.066 0.03 0.422
precentral -,415 0.003 0.013 0.467 -,311 0.02 0.096 0.267
rostralmiddlefrontal -,388 0.005 0.029 0.427 -,286 0.03 0.068 0.331
superior frontal -,381 0.005 0.071 0.323 -,401 0.004 0.05 0.373
frontal pole -0.091 0.278 0.249 0.051 -,293 0.027 0.238 0.06
Temporal
superior temporal -,413 0.003 -0.147 0.17 -0.195 0.102 0.037 0.407
middle temporal -,378 0.006 0.242 0.057 -0.207 0.089 ,338 0.012
inferior temporal -0.224 0.072 0.111 0.236 -,284 0.031 0.224 0.072
fusiform -,389 0.005 0.104 0.25 -,396 0.004 0.155 0.158
transverse temporal -0.11 0.238 0.142 0.179 -0.15 0.165 0.071 0.324
Entorhinal -,294 0.026 0.19 0.108 -,268 0.04 0.194 0.104
Temporal pole -,422 0.002 0.076 0.313 -,403 0.003 -0.063 0.343
parahippocampal -0.128 0.203 -0.094 0.272 -0.213 0.082 -0.166 0.141
Parieto-occipital
superior parietal -0.249 0.052 ,260 0.044 -,269 0.039 0.234 0.063
inferior parietal -,367 0.007 0.223 0.073 -,260 0.044 ,308 0.021
supramarginal -,251 0.05 0.181 0.12 -0.173 0.13 ,287 0.029
postcentral -,267 0.04 0.167 0.14 -0.227 0.069 0.186 0.113
precuneus -,291 0.028 0.108 0.243 -,298 0.025 0.064 0.339
lateral occipital -,361 0.008 ,305 0.022 -,356 0.009 ,301 0.024
lingual -,303 0.023 0.156 0.157 -,436 0.002 0.022 0.444
cuenus -0.162 0.147 0.179 0.122 -0.187 0.112 ,366 0.007
pericalcarine -0.016 0.459 0.072 0.322 -0.139 0.185 -0.078 0.307
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Table 5.12: Spearman correlation of nonsequential parameters with the cortical thickness of
ROIs in the control group
Left hemisphere Right hemisphere
Skipped beats Rule breaks Skipped beats Rule breaks
r p-value r p-value r p-value r p-value
Frontal
caudal middle frontal -.320 0.023 -0.124 0.226 -0.261 0.054 -0.128 0.219
lateral orbito frontal -0.23 0.079 0.038 0.41 -0.036 0.415 -0.124 0.226
medial orbito frontal -0.136 0.204 0.023 0.446 0.012 0.47 -0.053 0.375
pars opercularis -.303 0.03 -0.113 0.247 -.296 0.034 -0.135 0.206
pars orbitalis 0.175 0.143 0.21 0.099 -0.019 0.454 -.300 0.032
pars triangularis -.271 0.048 -0.139 0.199 -0.198 0.113 -0.083 0.309
precentral -.268 0.049 -0.21 0.099 -0.25 0.062 -0.173 0.147
rostralmiddlefrontal -.341 0.017 -0.045 0.393 -0.189 0.125 -.270 0.048
superior frontal -.318 0.024 -0.158 0.169 -.347 0.015 -0.229 0.08
frontal pole -0.261 0.054 -0.038 0.41 -0.187 0.127 -0.143 0.193
temporal
superior temporal -.351 0.014 -0.12 0.233 -.338 0.018 -0.195 0.117
middle temporal -.407 0.005 -0.165 0.157 -0.23 0.08 -0.143 0.193
inferior temporal -0.257 0.057 -0.165 0.157 -0.25 0.063 -0.15 0.181
fusiform -0.232 0.078 -0.165 0.157 -0.123 0.228 -0.008 0.482
transverse temporal -.290 0.037 -0.045 0.393 -.423 0.004 -.270 0.048
Entorhinal 0.038 0.41 -0.143 0.193 -0.01 0.476 -0.21 0.099
Temporal pole -0.092 0.289 0.098 0.277 0.068 0.34 0.161 0.163
parahippocampal -0.181 0.135 -0.075 0.325 0.021 0.449 -0.075 0.325
Parieto-occipital
superior parietal -0.208 0.101 0.094 0.285 -0.223 0.086 -0.101 0.270
inferior parietal -0.252 0.061 -0.135 0.206 -0.193 0.119 -0.06 0.358
supramarginal -.292 0.036 -0.143 0.193 -.427 0.003 -0.218 0.091
postcentral -.337 0.018 -0.098 0.277 -.480 0.001 -0.12 0.233
precuneus -.359 0.012 -0.233 0.077 -.342 0.017 -.270 0.048
lateral occipital -0.138 0.201 0.218 0.091 -0.149 0.182 0.158 0.169
lingual -.403 0.005 -0.225 0.084 -.324 0.022 -0.105 0.262
cuenus -0.221 0.088 -0.023 0.446 -0.077 0.321 -0.12 0.233
pericalcarine 0.058 0.364 -0.15 0.181 -0.167 0.155 -0.03 0.428

6 General Discussion
The present dissertation aimed to contribute to a better understanding of cognitive
impairment in MS patients and to characterize the link between neurostructural
changes and specific cognitive deficits. In the last part of this thesis, I will summary
and discuss the findings yielded by the empirical studies by elaborating on the open
research questions (see Chapter 3). Subsequently, the strengths and limitations
of these studies are discussed and, finally, clinical implication and suggestions for
future investigations are presented.
6.1 Cortical lesions and cognitive impairment
In the last decade several studies reported a correlation of the number and vol-
ume of cortical lesions with measures of cognitive impairment (M. Calabrese et al.,
2009; Roosendaal et al., 2009), physical disability (e.g M. Calabrese et al., 2007)
and other neurological symptoms such as epilepsy (M. Calabrese et al., 2011).
Moreover, prognostic validity has been proposed. It has also been shown that not
all MS patients show cortical lesions. However, to the best of our knowledge, no
research has yet been carried out to determine differences between patients with
and without cortical lesions. This fact lead to the question, whether patients with
and without cortical lesions differ, on the one hand, regarding cognitive function-
ing, and, on the other hand, regarding other important variables such as disease
duration, age or EDSS (first research question; Chapter 3). Additionally, neu-
roanatomical differences were brought into focus. Consequently, with our first
study we sought to identify these differences. We hypothesized that patients with
cortical lesions, compared to those without, would show diverse disease-associated
cognitive impairment and neuroanatomical characteristics.
The findings of the first study provide support for these hypotheses. First, regard-
ing cognitive functioning, we demonstrated that patients with and those without
visible cortical lesions differ from each other in mnestic functions, whereas the
groups did not deviate in any non-mnestic cognitive function. Moreover, patients
without cortical lesions show normal mnestic capacity compared with healthy con-
trols. This finding is in good agreement with previous studies stating the important
role of cortical lesions on cognition (e.g. M. Calabrese et al., 2009). Interestingly,
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we found the highest prevalence for cortical lesions bilateral in mesiotemporal re-
gions, with a particular prevalence in the parahippocampal gyri - a region highly
associated with memory functions. Roosendaal et al. (2009) described a compara-
ble regional association between accumulation of cortical lesions in mesio-temporal
areas and impairments in episodic memory.
Second, no differences were observed between the patient groups regarding the de-
mographical and disease-related characteristics. In accordance with the findings of
Calabrese and colleagues (2010), no significant correlation between cortical lesion
and disease duration or EDSS score was revealed. However, other authors found
a weak to moderate correlation between these variables (e.g Dalton et al., 2004).
Our findings indicate that cortical lesions can be found independent of age, age at
diagnosis or disease duration.
Third, concerning neuroanatomical differences, patients with cortical lesions exhib-
ited a thinner cortex than the other patient group, whose cortex was unimpaired.
Our findings of different cortical thickness in the two patient groups are suggestive
of a relationship between cortical inflammation and cortical atrophy. Given that
we do not have direct histopathological confirmation, we can only speculate that
cortical inflammation, indicated by cortical lesions, contributes at least partially
to the development of cortical atrophy in MS patients. So far it is known that
GM pathology involves both inflammatory and degenerative mechanisms, but the
relationship between the two is unclear and the question whether cortical atrophy
can occur as a result of focal cortical demyelination unanswered (M. Calabrese,
Magliozzi, et al., 2015). GM atrophy might be the final step of several patho-
logical processes, which could include cortical demyelination but also retrograde
degeneration secondarily to WM lesions, and perhaps, primary neurodegeneration
(Geurts et al., 2012).
To conclude, in this study we show that mnestic impairment is a typical charac-
teristic of cortical affection in MS and propose a so-called ‘cortically dominant’
MS subtype. Moreover, the study highlights the clinical relevance of visible DIR-
hyperintense cortical lesions in patients with RRMS insofar as it shows the asso-
ciation with neurodegenerative cortical thinning and mnestic dysfunction. Hence,
the first research question can be answered in the affirmative (see Chapter 3) in
terms of showing differences between MS patients with and without cortical lesions
in cognitive as well as in neurostructural characteristics other than cortical lesions.
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6.2 Topological cortical thinning and executive
dysfunction
Studies on executive functions in MS are rare, even though such impairments have
been observed in 15-20% of affected patients. Furthermore, their neural correlates
remain largely unexplored in MS. Despite the huge amount of correlation studies
between different structural alterations and broadly defined cognitive dysfunction
in MS (for a review see Rocca et al. (2015) or Chiaravalloti and DeLuca (2008)),
focal-topological studies on specific cognitive functions are missing. Based on this
research gap, the question about the global and focal neurostructural underpin-
nings of executive dysfunction rose (second research question; see Chapter 3).
With the second study we tried to answer this question.
In summary, the results of the second study revealed two important findings: First,
on the behavioral level, we found that executive dysfunction in MS patients ap-
pears to specifically affect fluency. It is known that a range of executive functions
is affected in MS patients and that some aspects of executive functions can be
more severely affected than others in the same individual. Our findings confirm
assumptions from Henry and Beatty (2006) who stated that tests of verbal fluency
are more sensitive to impairment in MS, relative to other measures of executive
functioning.
Second, we showed a lateralized clinico-anatomical correlation pattern between
fluency performance and cortical thickness in the anterior cingulate cortex, a find-
ing previously described in brain-damaged patients with large lesions only, for
example after stroke. The lateralized pattern described here appears novel and
quite unique in the literature on MS. This is in particular interesting, as MS is a
disease characterized by a widespread and largely symmetric pathology on both
behavioral and neuroanatomical level.
6.3 Randomization performance in patients with MS
and its neural correlates
Random number generation (RNG) has been recommended as a potentially pow-
erful tool for monitoring healthy subjects’ frontal executive functioning and their
attentional capacity. The behavioral pattern found in recent studies are strikingly
similar, showing subject-generated sequences to be far from ideal/mathematical
randomness. Our third research question (Chapter 3) emerged from the fact that,
despite an increasing number of behavioral and functional neuroimaging studies on
RNG in healthy subjects and a number of patient group, no study ever investigated
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the performance of MS patients in a RNG task. The neuroanatomical correlates
of RNG performance have also remained entirely unexplored. Consequentially, the
aim of our third study was two-folded. First, the study set out to examine the
impact of MS on randomization performance. Second, we wanted to explore the
anatomical correlates of RNG. We predicted an impaired randomization perfor-
mance by the MS patients relative to healthy controls as well as a considerable
correlation between behavioral parameters and structural disease characteristics,
such as atrophy and lesion indices.
The findings of the study support these two hypotheses. First, we showed that
random number sequences generated by MS patients are more stereotyped than
those of healthy control subjects. These results are in line with findings of pre-
vious studies, showing that sequences generated by brain damaged patients are
less random than these generated by healthy controls. In particular, a pronounced
counting tendency is a frequent finding in brain injured patients (e.g. Brugger
et al., 1996; Brown et al., 1998). Deviations from ’true’ sequential randomness
are typically ascribed to the limited capacity of working memory and executive
functions (Baddeley et al., 1998; Baddeley, 1966).
Beside the sequential non-randomness, patients exhibited - in contrast to healthy
controls - also problems in the non-sequential parameters, namely in keeping the
rhythm of paced number production (1Hz) and in not naming numbers laying out-
side the sampling interval. The former difficulty we consider a problem of speed
and thus consider the RNG task a useful tool for a brief and valid assessment of in-
formation processing speed. Also, the literature suggests that the pattern of RNG
performance in humans is unlikely to be driven purely by a limitation in execu-
tive functions. Instead, there is evidence that randomization performance of RNG
requires considerable allocation of attention (Jahanshahi et al., 2006). Second,
the behavioral-anatomical correlation analyses revealed that increased counting in
MS patients is associated with a wider third ventricle and higher cortical lesion
load. Moreover, an association between rhythm violations and widespread cortical
thinning was observed.
6.4 Memory, executive and speed deficits
For a long time, cognitive impairment in MS has been considered less important
than other types of impairment such as motor disability. Until the 1980s, it has
been thought of as a variant of subcortical dementia with a characteristic set of
deficits (Rao, 1986; Beatty et al., 1989). Currently, it is clear that MS-related cog-
nitive impairment has many facets. The clinical and neuroscientific understand-
ing of MS, and its associated cognitive deficits, has been substantially extended
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over the past 25 years. In other words, MS-related cognitive impairment seems
much more global than would be implied by the concept of ’subcortical dementia’
(Thornton & Raz, 1997). The three domains most commonly affected are pro-
cessing speed, memory and executive functions (Chiaravalloti & DeLuca, 2008).
The results of the three studies included in this dissertation are in line with the
’modern’ view of cognitive impairment in MS patients. Thus, the cognitive profiles
arising from the three studies cannot be defined as purely subcortical, but neither
as purely cortical. Besides, memory, executive and speed deficits figured as the
most commonly affected cognitive domains also in the present studies. Thus, not
all aspects of cognition are affected to the same extent, making it even harder for
a clinician to detect and monitor the cognitive decline in MS patients.
6.5 Relevance of cortical pathology in MS
Partly based on findings revealed by modern neuroimaging techniques, the classical
view of MS as an inflammatory demyelinating disease affecting primarily the WM
of the CNS was extended. It is now established that MS pathology also includes
neurodegeneration, and that GM structures such as the cerebral cortex can also
show focal lesions, atrophy, or both. Here we presented three studies, which in-
vestigated the neural correlates of different cognitive aspects. In all three studies,
cortical pathology - be it atrophy or lesions - was associated with behavioral per-
formance impairment. Considering the conflicting observations on the role played
by subcortical WM damage in determining the cognitive decline in MS (’clinico-
radiological paradox’, Barkhof (2002)), our data further strengthen the notion that
WM lesions do not fully account for the severity of cognitive impairment in MS,
but rather indicate that cortical pathology as one of the major structural changes
associated to MS-related cognitive dysfunction. In conclusion, in the last decade
much clinical and MRI research has convincingly demonstrated the importance
of cortical damage in MS. Thus, cortical pathology should be considered for di-
agnostic purposes and should be included among the diagnostic criteria for this
devastating disease.
6.6 Strengths and limitations of the present studies
Besides the study-specific strengths and limitations discussed in the respective pa-
pers, some general aspects should be mentioned here.
Many studies investigating cognitive impairment in MS are lacking a comprehen-
sive carefully selected neuropsychological set of tests. Most studies covered a
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limited range of neuropsychological tests or report only a global cognitive index.
Furthermore, data from a control group are often lacking. We used a broad num-
ber of standardized and validated tests, assessing a variety of cognitive functions.
The single tests were administered to a large cohort of MS patients (N=48) as
well as to a control group (N=48) in a standardized manner. The latter was ho-
mogeneous and matched in terms of demographical (age, gender) and educational
characteristics with the patient group. In contrast to many studies of the current
MS research using random cut-off points - determined by the researcher - to define
cognitive impairment, we used the matched control group in order to compare
our findings. Random cut-off points as well as the variability of assessment tools
are leading to a reduced inter-study comparability and reproducibility. Therefore,
a general agreement in defining reliable cut-off points for cognitive impairment
would be desirable.
A minimal education of an apprenticeship, i.e. 12 years, was an inclusion criteria
for all subjects in all studies, which may have resulted in a overrepresentation
of well-educated subjects in our cohort. According to the cognitive reserve hy-
pothesis, stating that greater lifetime intellectual enrichment lessens the negative
impact of brain disease on cognition (Stern, 2002, 2009), this overrepresentation of
well-educated subjects may have biased the cognitive performance of our patient
sample. Moreover, seriously affected patients were excluded from the study. In
summary, the inclusion of well-educated patients with only a mild to moderate af-
fection might reduce the representativeness of the cohort for MS patients at large.
Regarding the post processing of the MR data, some methodological challenges
need to be emphasized. For the measurement of cortical thickness, brain tissues
have been automatically segmented by classifying each vertex into WM, GM or
CSF. This segmentation is prone to error, because of the variable contrast of tissue
borders. Especially a high lesion load can cause problems and influence the seg-
mentation of WM and GM. With the visual inspection of the segmentation of each
subject, we were able to detect misclassifications. However, in only two patients a
manual correction was need due to grossly erroneous segmentation.
As stated in section 4.3.1, quantitative characterization of MS lesion load is of cen-
tral importance to clinical studies investigating the impact of lesions on cognitive
abilities. Even though fully automated methods are often applied, they are error
prone and less accurate than the manual segmentation of MS lesions. Thus, in the
studies presented here, lesion quantification was performed by a careful manual
delineation of all lesions. However, this method - in contrast to automated lesion
marking - is potentially the source of a different set of methodological shortcom-
ings. A variety of experimenter effects, conscious or unconscious to the image
rater, could have biased the findings.
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6.7 Clinical implication
Given the devastating effect MS-related cognitive impairment can have on working
capacity or general quality of life, the need for targeted interventions is evident.
The main driving motivation of this doctoral thesis was the need to better ex-
plain the complex manifestation of cognitive impairment, as cognitive capacity is
critical for a range of daily activities. Cognitive impairment results in consider-
able disruption of lifestyle, social and vocational activities, employment status and
level of independent living by causing problems even in routine household tasks.
Improving the knowledge of the pathophysiology of cognitive impairment in MS
and the identification of the mechanisms responsible for its evolution over time,
will contribute to the development of improved and efficient treatment strategies.
Moreover, the identification of target structures helps to develop innovative phar-
macological and behavioral therapies to enhance cognitive function in MS, which
are still scant. Thus, the need for increased awareness of cognitive impairment
is essential for the development of effective therapy concepts and rehabilitation
programs. Assuming that cognitive decline emerges early in the disease course,
early detection and therapy may prevent from deterioration of cognition and may
help with treatment decisions.
6.8 Implications for future work
The present work confirms and extends previous research investigating the neu-
roanatomical underpinnings of cognitive impairment in MS. While there is an
extensive cross-sectional literature pertaining to the prevalence and pattern of
cognitive impairment in MS, much less is known about the rate and pattern of
cognitive deterioration that occurs over the course of illness. Furthermore, only
few parameters have been identified as a predictor for cognitive impairment. Thus,
additional markers that could be assessed early in the disease are badly needed.
Imaging characteristics may provide crucial information on the evolving disease
and the development of cognitive impairment. By aligning longitudinal study de-
signs, future studies including broad neuropsychological and multiparametric MRI
assessment are mandatory to provide new and important insights of the pathogenic
underpinnings of cognitive impairment in MS.
With today’s imaging techniques, it is only possible to visualize the ’tip of the ice-
berg’ of cortical MS lesions (Seewann et al., 2011). Further progress in detection
algorithms and the development of new MRI sequences and modern imaging tech-
niques can be expected and will likely improve our understanding of MS pathology,
symptoms, and treatment.
76 General Discussion
Furthermore, only recently MRI research in MS has drawn its attention to subcor-
tical structure changes and its association with cognitive impairment. Although
volume loss in the basal ganglia and thalamus has been identified, only little is
known about its association to cognitive impairment and its progression. Thus,
well-designed correlational studies might identify the role of subcortical changes
and the respective structure-function relationship.
Research from the past few years highlights the significance of lesion-independent
normal-appearing WM abnormalities, which is characterized by the presence of
axonal spheroid and swellings, mild inflammation, microglial activation, gliosis
and increased expression of proteolytic enzymes. An association with cognitive
dysfunction has been proposed. Abnormalities of the normal-appearing WM and
diffuse injury to GM, assessed with quantitative MRI techniques, are important in
determining cognitive impairment in patients with MS. Thus, structural connectiv-
ity analyses like fiber tracking will be needed to more fully understand MS-related
WM fiber abnormalities.
Regarding cognitive dysfunction there is also some work to be done. Since the clin-
ical manifestation of MS-related cognitive impairment is not sufficiently described
by the traditional ‘single pattern’ concept of subcortical dementia, the development
of a typology of several neuropsychological MS profiles is worthwhile. Therefore,
large datasets that include comprehensive cognitive tests and questionnaire results
as well as MRI markers are needed. This approach could be pursued by a struc-
tural equation modeling approach building composite scores (Ullman, 2006). It
seems reasonable to develop such typology in a widespread and inhomogeneous
disease such as MS, instead of describing a single pattern or parameter. Such ty-
pology might, for example, facilitate prognosis, risk stratification, and treatment
recommendations.
6.9 Conclusion
The clinical and neuroscientific understanding of MS has been substantially ex-
tended over the past 25 years. In addition to the notion of an inflammatory
demyelinating WM disease, it is now established that the MS pathology includes
neurodegeneration, and that the GM of the CNS can also be affected. Embed-
ded in this paradigm shift, neuropsychological studies have revealed that cognitive
impairment is frequently observed in all MS subtypes at all stages of the disease,
and that its clinical manifestations are heterogeneous. With the recognition of the
importance of cognitive functioning in MS arises a responsibility on the part of
both clinicians and researchers to seek to increase understanding of these cognitive
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deficits. With this doctoral thesis we make a significant contribution to the re-
search field of cognitive impairment in MS patients by adding a small puzzle piece
to the immense work already done.
In line with the paradigm shift, the relevance of cortical pathology for cognitive
impairment has been highlighted in the present work. Moreover, it has been elabo-
rated on different aspects of cognitive impairment in MS patients and its underlying
neural correlates: 1) The appearance of cortical lesion in mesiotemporal structures
is associated with memory deficits, 2) cortical thinning in the anterior cingulate
cortex predicts fluency deficits and 3) widespread cortical thinning and cortical
lesion load - together with central brain atrophy - correlate with poor performance
on a random number generation task, engaging a number of executive functions
and processing speed.
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